Copy of Order dated 09-OCT-2019 rendered by Chief Justice Crampton concerning the destruction of exhibits tendered into evidence placed on file. Original filed on Court File No. T-967-76

Correspondence between the Registry and the Plaintiff pursuant to the letter sent on December 12, 2018 regarding the return of exhibits. placed on file on 08-JUL-2019

Correspondence between the Registry and the Plaintiff pursuant to the letter sent on December 12, 2018 regarding the return of exhibits. placed on file on 05-JUL-2019

Correspondence between the Registry and the Plaintiff pursuant to the letter sent on December 12, 2018 regarding the return of exhibits. placed on file on 05-JUN-2019

Memorandum to file from J. Lalonde dated 12-DEC-2018 A letter was sent to the parties by CAS Records Management Services on December 12, 2018, inviting them to withdraw their respective exhibits put into evidence. placed on file.

Solicitor's certificate of service on behalf of Jane Caskey confirming service of Doc 190, 191 upon Defendant by telecopier on 15-MAY-2014 filed on 15-MAY-2014

Discontinuance on behalf of the parties filed on 15-MAY-2014

Consent on behalf of all parties to filing the notice of discontinuance attached hereto as schedule A filed on 15-MAY-2014

Payment of Court fees (ARV#1475) in the amount of $350.00 recd on April 14, 2014 from Goodmans LLP and placed on file on 23-APR-2014

Payment of Court fees (ARV#1478) in the amount of $1,050.00 received from Norton Rose Fullbright Canada LLP on April 10, 2014.

Payment of Court fees (ARV#1477) in the amount of $350.00 received from Sprigings Intellectual Property Law on April 15, 2014.

Payment of Court fees (ARV#1476) in the amount of $350.00 received from Gardiner Roberts LLP on April 7, 2014.

Request for payment of Court Fees (ARV#1478) in the amount of $1050.00 sent to Norton Rose Fullbright Canada LLP placed on file on 21-MAR-2014

Request for payment of Court Fees (ARV#1477) in the amount of $350.00 sent to Sprigings Intellectual Property Law placed on file on 21-MAR-2014

Request for payment of Court Fees (ARV#1476) in the amount of $350.00 sent to Gardiner Roberts LLP placed on file on 21-MAR-2014

Request for payment of Court Fees (ARV#1475) in the amount of $350.00 sent to Goodmans LLP placed on file on 21-MAR-2014

MEMORANDUM to Case Management Judge, Aronovitch, P., from Cynthia Leaver, Ottawa Registry, enclosing copy of DISCONTINUANCE filed 3-MAR-2014 in Federal Court of Appeal file A-397-13 (consolidated with A-398-13) placed on file on 06-MAR-2014

Copy of NOTICE OF DISCONTINUANCE in Federal Court of Appeal file # A-397-13 (consolidated with A-398-13) placed on file on 06-MAR-2014 Original filed on Court File No. A-397-13

List of Exhibits on behalf of all parties received at hearing on 14-FEB-2014

Toronto 13-JAN-2014 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Trial in this action Result of Hearing: Matter adjourned sine die held in Court Senior Usher: Lisa Tirado 13-JAN-2014 Lisa Tirado 14-JAN-2014 Lisa Tirado 15-JAN-2014 Mike Gaida 20-JAN-2014 Mike Gaida 21-JAN-2014 Mike Gaida 23-JAN-2014 Mike Gaida 24-JAN-2014 Greg Nevin 27-JAN-2014 Greg Nevin 28-JAN-2014 Joe Mischuk 29-JAN-2014 Joe Mischuk 30-JAN-2014 Joe Mischuk 31-JAN-2014 Frank Kurina 03-FEB-2014 Noel Nation 04-FEB-2014 Frank Kurina 05-FEB-2014 Frank Kurina 06-FEB-2014 Lisa Tirado 10-FEB-2014 Duration per day: 13-JAN-2014 from 09:35 to 14:10 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 14-JAN-2014 from 09:30 to 13:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 15-JAN-2014 from 09:30 to 12:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 20-JAN-2014 from 09:30 to 12:10 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 21-JAN-2014 from 09:28 to 16:20 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 23-JAN-2014 from 09:28 to 11:45 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 24-JAN-2014 from 09:32 to 11:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 27-JAN-2014 from 09:30 to 11:25 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 28-JAN-2014 from 09:30 to 10:25 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 29-JAN-2014 from 09:30 to 16:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Shirley Aciro 30-JAN-2014 from 09:30 to 17:30 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 31-JAN-2014 from 08:58 to 10:19 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 03-FEB-2014 from 09:28 to 17:02 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 04-FEB-2014 from 09:28 to 16:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 05-FEB-2014 from 09:29 to 17:02 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 06-FEB-2014 from 09:27 to 16:57 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith 10-FEB-2014 from 09:30 to 16:33 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jacqueline Smith Total Duration: 17d Appearances: Mr. Patrick Kierans 416-216-4000 representing Plaintiff Ms. Jordana Sanft 416-216-4000 representing Plaintiff Mr. Daniel Daniele 416-216-4000 representing Plaintiff Ms. Jane Caskey 416-216-4000 representing Plaintiff Ms. Amy Grenon 416-216-4000 representing Plaintiff Ms. Carol Hitchman 416-865-6600 representing Defendant Ms. Alisse Houweling 416-865-6600 representing Defendant Mr. Warren Sprigings 416-777-0888 representing Defendant Mr. Christopher Tan 416-777-0888 representing Defendant Mr. Harry Radomski 416-979-2211 representing Defendant Mr. Jerry Topolski 416-979-2211 representing Defendant Mr. David Scrimger 416-979-2211 representing Defendant Ms. Jenene Roberts 416-979-2211 representing Defendant Mr. Ken Crofoot 416-979-2211 representing Defendant Exhibits filed at hearing: A-1 to A-56 APO 1- to APO 3 GSK 1 to GSK 22 Witness(es) on behalf of Plaintiff Dr. Hans Maag Murna, Germany on behalf of Plaintiff Mr. Stephen Graham Davies Oxford, UK on behalf of Defendant Dr. Jennifer Dressman Frankfurt, Germany on behalf of Plaintiff Dr. Barbara Romanowski Edmonton, AB, Canada on behalf of Defendant Dr. Robert Langer Cambridge, MA, USA on behalf of Defendant Dr. Jonathan Dordick Schenecyady, NY, USA on behalf of Defendant Dr. Stephen Hanessian Beaconsfield, QC. Canada on behalf of Defendant Dr. Clyde S. Crumpacker Boston MA, USA on behalf of Defendant Dr. Michael Mayersohn, Marana, AZ, USA on behalf of Defendant Dr. Paul A. Lasker Napa, CA

Solicitor's certificate of service on behalf of Jesse Todres confirming service of doc. 188 upon Defendants and Plaintiffs by Counterclaim by telecopier on 20-JAN-2014 filed on 20-JAN-2014

Notice Under the Canada Evidence Act on Behalf of the Plaintiffs and Defendants by Counterclaim filed on 20-JAN-2014

Writ of Subpoena Ad Testificandum to Mr. Jean-Louis Gelinas, President, Pharmapar Inc. issued on 03-FEB-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Defendants/Plaintiffs by Counterclaim filed on 03-FEB-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum Directed to Jean-Guy Goulet issued on 28-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 28-JAN-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum Directed to Richard Guest issued on 28-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 28-JAN-2014 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum Directed to Suresh Kalidoss issued on 28-JAN-2014 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 28-JAN-2014 Tariff any other proceeding - $30.00

Solicitor's certificate of service on behalf of Christopher Guerreiro confirming service of doc 179 upon all parties by personal service on 27-JAN-2014 filed on 27-JAN-2014

Expert report of Dr. Arthur H. Neufeld on behalf of the Plaintiffs Volume 1 is confidential filed on 27-JAN-2014

Acknowledgment of Receipt received from all parties with respect to doc. 176 and 176- Reasons for Order and Order, dated 20-jan-2014 and Certificate of Order, dated 20-jan-2014 placed on file on 20-JAN-2014

Certificate of Order respect to the Reasons for Order (doc. 176_) filed on 20-JAN-2014

Reasons for Order and Order dated 20-JAN-2014 rendered by The Honourable Mr. Justice Manson Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 155 Result: 1)PMS and Apotex's motion is granted with respect to paragraphs 1-13, 17-21 and 27-34 of the Affidavit of Dr. Paul Laskar. 2) PMS and Apotex's motion is otherwise dismissed, 3) cost to GSK in the cause. Filed on 20-JAN-2014 certified copies sent to parties Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1217 page(s) 187 - 187

Solicitor's certificate of service on behalf of Daniel Daniele confirming service of doc. 174 upon Defendant by personal service on 16-JAN-2014 filed on 16-JAN-2014

Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 16-JAN-2014

Sealed envelope pursuant to protective order, dated 29-sep-2010 on behalf of Plaintiff purporting to contain Plaintiff-GSK's Responding Motion Record(docs: 172 173) Filed on 16-JAN-2014

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 155 filed on 16-JAN-2014

Affidavit of Scott Werry sworn on 16-JAN-2014 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 155 with Exhibits a-n filed on 16-JAN-2014

Letter from Defendant dated 15-JAN-2014 regarding Pharmascience's expert reports relating to damages claim by GSK as follows: Dr. Christine Meyer(9-jan-2014), Dr. Andrew Ching(13-jan-2014), Mr. Doug Welsh(13-Jan-2014). AFOREMENTIONED REPORTS ATTACHED. received at hearing on 15-JAN-2014

CONFIDENTIAL: Opening Compendium for the Defendant filed at hearing on 13-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 09-JAN-2014 directing that Upon hearing from counsel at a case management conference on January 9, 2014 to the stipulatins agreed to by parties, the Trial in the above noted files will now commence on Monday January 13, 2014 sitting at 9:30 a.m. to 5:00 p.m. and until 12:00 p.m. on Fridays. placed on file on 09-JAN-2014 Confirmed in writing to the party(ies)

Ottawa 09-JAN-2014 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference To discuss scheduling issues in this file and in T-14-09 and T-643-10 Result of Hearing: The Court directed that the Trial of the matter would commence on Monday January 13, 2014, commencing at 9:30 a.m. to 5:00 p.m. and until 12:00 p.m. on Fridays. held by way of Conference Call Duration per day: 09-JAN-2014 from 02:00 to 02:30 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 30min Appearances: Ms Sanft, Mr. Kierans and Ms Caskey 416-216-4798 representing GSK Mr. Sprigings and Mr. Tan 416-777-2273 representing Pharmascience Ms Hitchman and Ms Houweling 416-865-8259 representing Pharmascience Mr. Radomski, Mr. Toposki and Mr. Scrimger 416-597-4141 representing Apotex Comments: For full minutes see the minutes in T-14-09. The Court will issue a Direction shortly. Minutes of Hearing entered in Vol. 895 page(s) 67 - 68 Abstract of Hearing placed on file

Covering letter from Defendant dated 09-JAN-2014 concerning Doc. No. 169 placed on file on 09-JAN-2014

Affidavit of service of Alisse Houweling sworn on 09-JAN-2014 on behalf of Pharmascience Inc. ET AL. and Apotex Inc. confirming service of Doc.169 and Book of Authorities upon all parties by personal service on 09-JAN-2014 filed on 09-JAN-2014

Book of Authorities consisting of 1 volume(s) on behalf of Pharmascience Inc. ET AL., and Apotex Inc. received on 09-JAN-2014

Sealed envelope pursuant to Court Order dated 6-JAN-2014 on behalf of Pharmascience Inc. ET AL. and Apotex Inc. purporting to contain Motion for Reply Expert Evidence Filed on 09-JAN-2014

Acknowledgment of Receipt received from all parties with respect to the amended protective and confidentiality order dated 6-Jan-2014 placed on file on 06-JAN-2014

Confidentiality and Protective Order dated 06-JAN-2014 rendered by The Honourable Mr. Justice Manson Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 167 Result: granted Filed on 06-JAN-2014 certified copies sent to parties entered in J. & O. Book, volume 1215 page(s) 303 - 314 Interlocutory Decision

Acknowledgment of Receipt received from all parties with respect to the amended direction of the Court dated 3-Jan-2014 (ID 686) placed on file on 06-JAN-2014

Acknowledgment of Receipt received from all parties except GSK with respect to the direction dated 3-Jan-2014 (ID 685) placed on file on 03-JAN-2014

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 3-Jan-2014 scheduling a CMC on 3-Jan-2014 at 1:30 p.m. placed on file on 03-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 03-JAN-2014 directing that having considered Ms. Hitchman's correspondence dated January 3, 2014, I amend my direction as follows: Apotex and Pharmascience shall serve and fuile the written reporesentations for the motion by 2 pm on Thursday, January 9, 2014; GSK shall serve and file its repsponding written representations by no later than 2 pm on Thursday, January 16, 2014; The motion will be heard on January 20, 2014 placed on file on 03-JAN-2014 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 03-JAN-2014 directing that having considered the parties correspondence dated January 2, 2014, I I direct as follows: Apotex and PMS will complete their Motion Record including any affidavit and written argument by January 7, 2014; GSK will serve any responding affidavits by January 9, 2014; Cross-examinations on any affidavits will be completed by January 10, 2014; GSK will serve and file its responding record by January 16, 2014; The motion for leave to file reply expert report will be heard on January 20, 2014; Accordingly, the case management conference scheduled to take place today at 1:30 p.m. will not proceed placed on file on 03-JAN-2014 Confirmed in writing to the party(ies)

Letter from Pharmascience dated 03-JAN-2014 advising that the parties came to an agreement re: schedule to perfect the motion for leave and requesting that the direction of the Court issued earlier be amended accordingly (sent to the trial judge on 3-Jan-2014) received on 03-JAN-2014

Acknowledgment of Receipt received from all parties (GSK over the phone) with respect to the direction of the Court dated 2-Jan-2014 placed on file on 02-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 03-JAN-2014 directing that a case management conference will take place on January 3, 2014 at 1:30 p.m. to discuss the scheduling of the motion for leve to file reply expert evidence placed on file on 03-JAN-2014 Confirmed in writing to the party(ies)

Letter from GSK dated 02-JAN-2014 in response to Apotex's letter of 2-Jan-2014 and proposing a schedule in the event the Court directs that the motion be heard on 20-Jan-2014 received on 02-JAN-2014

Letter from Apotex dated 02-JAN-2014 advising of issues with hearing the motion for leave on January 13th and and proposing a schedule which would make the motion returnable on January 20, 2013 received on 02-JAN-2014

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 02-JAN-2014 directing that GSK to serve any responding affidavits to Apotex motion materials filed December 2, 2013 by January 6, 2014; Any cross-examinations on the affidavits of all parties, if any, to be conducted by January 8, 2014; GSK to file and serve its responding record by January 9, 2014; any reply and motion to be heard January 13, 2014 placed on file on 02-JAN-2014 Confirmed in writing to the party(ies)

Letter from PMS dated 31-DEC-2013 in response to GSK's letter dated 30-Dec-2013 (sent to Trial Judge on 2-Jan- 2014) received on 31-DEC-2013

Letter from GSK dated 30-DEC-2013 suggesting that Apotex and Pharmascience's motion for leave to file reply expert evidence be heard prior to Apotex and Pharmascience's evidence on validity and response to infringement and requesting that a timetable be set for perfecting the motion received on 30-DEC-2013

Copy of a Letter from Plaintiff to Defendant GSK dated 28-NOV-2013 regarding redacted documents received on 28-NOV-2013

Memorandum to file from Toronto dated 18-DEC-2013 The complete motion record please see Court file T-14-09 placed on file.

Notice of Motion on behalf of Glaxosmithkline Inc et al. in writing(on consent) for the trial judge, Mr. Justice Manson for An Order varying the Protective Order in Court file T-14-09; An Order varying the Further Amended Protective Order and Confidentiality Order pursuant to R.151 in Court file T-2109-09; An Order varying the Amended Confidentiality and Protective Order pursuant to R.151 in Court file: T-643-10; such further and other relief filed on 18-DEC-2013 Draft Order\\Judgment received.

Covering letter from GSK dated 12-DEC-2013 concerning Doc. No. 166 placed on file on 13-DEC-2013

Copy of written directions dated 17-DEC-2013 rendered by The Honourable Mr. Justice Manson placed on file. Original filed on Court File No. T-14-09

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 17-DEC-2013 directing that having considered the submissions of counsel concerning my direction on December 10, 2013, paragraph 4 of the draft Direction submitted to the Court on December 13, 2013 should be deleted. While the acknowledgment by GlaxoSmithKline Inc. et al (GSK) that the third party reports ordered produced are not privileged does not act as a waiver of priviledge in respect of any other documents or information not contained in the reports, the direction does not need to, nor should it, extend to any such hypothetical; documents or information not in issue placed on file on 17-DEC-2013 Confirmed in writing to the party(ies)

Letter from counsel for PMS in T-643-10 dated 16-DEC-2013 providing submissions in response to GSK's re: why par. 4 should not be included in the direction arising out of the CMC held on 10-Dec-2013 received on 16-DEC-2013

Letter from GSK dated 13-DEC-2013 providing a draft direction arising out of the CMC held on 10-Dec-2013 and submissions supporting their position with regards to par. 4 of the draft direction received on 13-DEC-2013

Sealed envelope pursuant to the Protective Order dated 29-Jun-2011 on behalf of Plaintiffs purporting to contain the Expert Report of Dr. Stephen Graham Davies dated 22-May-2013 and doc 165 (only two copies filed and 1 sent directly to the trial judge) Filed on 13-DEC-2013

Certificate of Solicitor Jordana Sanft attaching thereto the proposed evidence of expert witness Dr. Stephen Graham Davies on behalf of Plaintiffs filed on 13-DEC-2013

Covering letter from Plaintiffs dated 10-DEC-2013 concerning Doc. Nos. 162 164 placed on file on 11-DEC-2013

Memorandum to file from Julie Dulac dated 11-DEC-2013 the Expert Report of Dr. Barbara Romanowski dated 19-Oct-2013 which is also applicable to this file, was filed in T-14-09 as doc. 127 placed on file.

Vancouver 04-DEC-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Motion Doc. No. 145 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Heather Richards Duration per day: 04-DEC-2013 from 09:10 to 11:35 Courtroom : Courtroom No. 601 - Vancouver Court Registrar: Sandra McPherson Total Duration: 2h25min Appearances: Ms Allyson Whyte-Nowak (Norton Rose Canada LLP) 1.416.216.1899 representing Plaintiff - (Glaxosmith-Kline, Inc) HB Radomski/Jerry Topolski (Goodmans LLP) 1.416.979.2211 representing Plaintiff Warren Sprigings/Christopher Tan (Sprigings IP) 1.416.777.0888 representing Defendant Court Reporter: Sharon Leeburn - All-West Court Reporters Vancouver BC 604.683.4774 04-DEC-2013 Transcript not requested Minutes of Hearing entered in Vol. 893 page(s) 183 - 184 Abstract of Hearing placed on file

Sealed envelope pursuant to Protective Order dated 29-Jun-2011 on behalf of Plaintiffs purporting to contain the Expert Report of Dr. Iain Cockburn dated 3-Dec-2013 (GSK's Infringement Damages T-2101-09) and doc. 163 (only 2 copies filed and 1 sent directly to the trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Amy E. Grenon attaching thereto the proposed evidence of expert witness of Iain Cockburn on behalf of Plaintiffs filed on 11-DEC-2013

Sealed envelope pursuant to Protective Order dated 29-Jun-2011 on behalf of Plaintiffs purporting to contain the Expert Report of Mr. Ross Hamilton dated 22-May-2013 (GSK's Infringement Damages T-2101-09) and doc. 161 (only 2 copies filed and 1 sent directly to the trial judge) Filed on 11-DEC-2013

Certificate of Solicitor Jane E. Caskey attaching thereto the proposed evidence of expert witness Mr. Ross Hamilton dated 22-May-2013 (GSK's Infringement Damages T-2101-09) on behalf of plaintiffs filed on 11-DEC-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 27-Nov-2013 placed on file on 28-NOV-2013

Memorandum to file from Julie Dulac dated 11-DEC-2013 one copy of the expert reports of Dr. Clyde S. Crumpacker II and Dr. Robert Langer were filed in T-14-09 (docs 122 and 123) and sent directly to the trial judge placed on file.

Ottawa 10-DEC-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss the issues with the filing of expert reports and privilege issues and correspondence dated 2-Dec-2013 from GSK Result of Hearing: Direction to follow held in chambers by way of Conference Call Duration per day: 10-DEC-2013 from 12:30 to 12:48 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 20min Appearances: Harry Radomski, Jerry Topolski and Dave Scrimger 416-597-4142 representing Apotex Jordana Sanft, Jane Caskey, Patrick Kierans and Amy Grenon 416-216-4798 representing GSK Carol Hitchman and Alisse Houweling 416-859-2722/416-865-4010 representing Pharmascience in T-2101-09 and T-643-10 Draft Decision to be submitted by counsel for GSK Minutes of Hearing entered in Vol. 893 page(s) 97 - 98 Abstract of Hearing placed on file

Covering letter from GSK dated 29-NOV-2013 concerning Doc. No. 159 placed on file on 29-NOV-2013

Solicitor's certificate of service on behalf of Daniel Daniele confirming service of doc. 159 upon Counsel for Apotex, PMS in T-2101-09 and PMS in T-643-10 by telecopier on 29-NOV-2013 filed on 29-NOV-2013

GSK's Patent Claims Chart filed on 29-NOV-2013

Claims Chart of Apotex Inc. and Pharmascience Inc. et al. (cc'd to counsel for GSK and counsel for PMS in T-2101-09) filed on 29-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 06-DEC-2013 directing that a case management conference by telephone conference is scheduled to take place on Tuesday December 10, 2013 at 12:30 EST placed on file on 06-DEC-2013 Confirmed in writing to the party(ies)

Copy of Order dated 06-DEC-2013 rendered by The Honourable Mr. Justice Manson concerning Notice of Motion doc. 145 placed on file. Original filed on Court File No. T-14-09

Letter from GSK dated 06-DEC-2013 requesting a CMC to discuss issues with filing of expert reports and attaching correspondence between the parties on the subject (sent to Mr. Justice Manson by e-mail on 6-Dec-2013) received on 06-DEC-2013

Letter from Defendant dated 03-DEC-2013 seeking directions on motion materials and a date for a hearing received on 03-DEC-2013

Solicitor's certificate of service on behalf of Alisse Houweling confirming service of Doc 156 upon all parties by process server on 02-DEC-2013 filed on 02-DEC-2013

Sealed envelope pursuant to Protective Order dated January 12, 2011 rendered by Madam Aronovitch on behalf of Pharmascience Inc. et. al. purporting to contain Motion for Leave to File Reply Expert Evidence Filed on 02-DEC-2013

Notice of Motion contained within a Motion Record on behalf of Pharmascience Inc. et al 10-Jan-2014 for an Order granting leave to Pharmascience and Apotex to file the report of an additional expert; An Order granting leave to Pharmascience and Apotex to file the reply expert reports of Dr. Gordon Amidon, Dr. Jonathon Dordick, Dr. Stephen Hanessian and Dr. Paul Lasker; Costs of motion filed on 02-DEC-2013

Letter from Pharmascience Inc. et al dated 02-DEC-2013 "...Kindly bring this letter to the attention of Justice Manson...Please find enclosed the notice of motion and proposed reply expert reports of Apotex Inc. (T-14-09)...which are being filed pursuant to the Order of Justice Manson dated Nov 8, 2013..." received on 02-DEC-2013

Letter from Apotex dated 02-DEC-2013 in response to GSK's letter dated 2-Dec-2013 (sent to Manson J. by e-mail on 3-Dec-2013) received on 02-DEC-2013

Letter from GSK dated 02-DEC-2013 providing a status of the privilege issue and requesting the issuance of a direction in advance of producing the documents (sent to Manson J. by e-mail on 3-Dec-2013) received on 02-DEC-2013

Copy of Notice of Appeal (Appeal Court File No. A-397-13 ) appealing the Order of Manson J. dated 26-Nov-2013 filed in the Court of Appeal on 27-NOV-2013 on behalf of Pharmascience et al placed on file on 28-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 27-NOV-2013 directing that if the parties cannot agree on production of the transfer pricing documents by GSK for the years 2005 through 2008, by Friday November 29, 2013, GSK will forward a brief with sufficient particulars to opposing counsel and to the Court, specifying the origin and recipient of each document for which solicitor-client priviledge is claimed and the reason for the claim of privilege for each such document. GSK will also supply a copy of each such document, under seal, to the Court only. GSK is to file the brief and documents, in Vancouver, to my attention, no later than noon on December 2, 2013. Counsel for Apotex and PMS shall have until 4:30 pm EST on December 3, 2013, to serve and file any responding brief to GSK's brief and the matter will be heard by me on December 4, 2013, in Vancouver placed on file on 27-NOV-2013 Confirmed in writing to the party(ies)

Letter from Apotex (Plaintiff in T-14-09) dated 27-NOV-2013 advising that Apotex and PMS can confirm that they are able to provide the Court with 5 expert reports at this time (sent to Manson J. by e-mail on 28-Nov-2013) received on 27-NOV-2013

Ottawa 27-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss privilege issues raised in GSK's correspondence dated 26-Nov-2013 Result of Hearing: see abstract in T-14-09 held in chambers by way of Conference Call Duration per day: 27-NOV-2013 from 02:30 to 02:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 10min Appearances: Jerry Topolski 416-597-5907 representing Apotex in T-14-09 Jane Caskey and Dan Daniele 416-216-2317 representing GSK Christopher Tan 416-777-2647 representing PMS Minutes of Hearing entered in Vol. 892 page(s) 48 - 49 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the Order of the Court dated 26-Nov-2013 placed on file on 26-NOV-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 21-Nov-2013 placed on file on 21-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 26-NOV-2013 directing that a case management conference by telephone conference will take place on November 27, 2013 at 2:30 p.m. (to discuss the issues raised in GSK's letter dated 26-Nov-2013) placed on file on 26-NOV-2013 Confirmed in writing to the party(ies)

Copy of Order dated 26-NOV-2013 rendered by The Honourable Mr. Justice Manson concerning motion doc. 150 placed on file. Original filed on Court File No. T-14-09

Letter from GSK dated 26-NOV-2013 requesting a direction of the Court relating to an issue with privilege (sent ot Manson J. by e-mail on 26-Nov-2013) received on 26-NOV-2013

Draft Order concerning Motion Doc. No. 150 consented to by all parties received on 25-NOV-2013

Solicitor's certificate of service on behalf of Daniel Danielle confirming service of Doc. No. 153 upon Defendants by personal service on 22-NOV-2013 filed on 22-NOV-2013

Trial Chart on behalf of the Plaintiffs filed on 22-NOV-2013

Letter from Pharmascience in T-643-10 dated 22-NOV-2013 attaching a draft order re: motion doc. 150 not consented to by GSK received on 22-NOV-2013

Solicitor's certificate of service on behalf of Daniel Daniele confirming service of Doc. No. 151 (ID#628) upon Defendants by personal service (Gardiner Roberts LLP) and process server (Sprigings) on 22-NOV-2013 filed on 22-NOV-2013

Trial Record on behalf of Plaintiffs filed on 22-NOV-2013

Ottawa 21-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference the Court's direction dated 19-Nov-2013 requiring the expert reports to be filed Result of Hearing: The Court asked for a report by November 29th on what report will be available to the Court when and the reports the parties are sure to rely on would be filed by December 6, 2013. The parties are therefore relieved from having to comply with the November 19th direction. held in chambers by way of Conference Call Duration per day: 21-NOV-2013 from 03:30 to 04:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jerry Topolski and Harry Radomski 416-597-5907 representing Apotex in T-14-09 Patrick Kierans, Jordana Sanft, Daniel Daniele, Amy Grenon 416-216-2317 representing GSK Carol Hitchman and Alisse Howeling 416-865-8259 representing Pharmascience Christopher Tan 416-777-2647 representing Pharmascience in T-643-10 Minutes of Hearing entered in Vol. 891 page(s) 400 - 401 Abstract of Hearing placed on file

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 21-NOV-2013 directing that GSK's motion to amend will be heard in Vancouver on December 4, 2013 at 9:00 a.m. for 1 day. Apotex's and PMS' responding motion record including transcripts of cross-examinations but without written argument will be served and filed, in Vancouver, by noon, on December 2, 2013. Apotex's and PMS' responding written argument will be served and filed electronically at cmt ottawa@cas-satj.gc.ca by December 2, 2013 placed on file on 21-NOV-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 20-NOV-2013 indicating that the parties are available for the hearing of GSK's motion to amend on December 4, 2013 in Vancouver at 9:00 a.m and suggesting a schedule for the filing of responding material received on 21-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 20-NOV-2013 directing that a case management telephone conference will take place on November 21, 2013 at 3:30 p.m. placed on file on 20-NOV-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 19-NOV-2013 directing that any expert report in cheif and in rebuttal served between the parties to date shall be submitted for filing with the Court by November 27, 2013. Any expert report which is due to be serve prior to trial shall be submitted for filing with the Court on the date it is due to be served placed on file on 19-NOV-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 20-NOV-2013 requesting a CMC with Manson J. to discuss certain issues in relation to the direction dated 19-Nov-2013 received on 20-NOV-2013

Toronto 12-NOV-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Motion Doc. No. 150 on behalf of Defendant Result of Hearing: Matter reserved held in Court Senior Usher: Joe Mischuk Duration per day: 12-NOV-2013 from 09:35 to 15:31 Courtroom : Courtroom No. 4-B - Toronto Court Registrar: Heather Michaud Total Duration: 5h 56min Appearances: Jane E. Caskey 416-216-1899 representing Plaintiff Amy Grenon 416-216-1931 representing Plaintiff Christopher G. T. Tan 416-777-2647 representing Defendant Warren Sprigings 416-777-2273 representing Defendant Draft Decision to be submitted by the parties Comments: Laptop Z006122 was used to record this hearing. Heard together with T-14-09 and T-643-10. Minutes of Hearing entered in Vol. 890 page(s) 309 - 325 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 5-Nov-2013 placed on file on 05-NOV-2013

Copy of Order dated 08-NOV-2013 rendered by The Honourable Mr. Justice Manson concerning CMC held 08-Oct-2013 and 11-Oct-2013 setting a timetable placed on file. Original filed on Court File No. T-14-09

Memorandum to file from Julie Dulac dated 08-NOV-2013 the material submitted in support of motion doc. 150 was filed in file T-14-09 (doc. 99 and authorities) placed on file.

Sealed envelope purporting to contain the Notice of Motion on behalf of Apotex (in T-14-09) and Pharmascience Inc. et al. returnable at Special Sitting in Toronto on 12-NOV-2013 to begin at 09:30 for an Order compelling the representatives of the Responding Parties, GlaxoSmithKline Inc....to provide answers to the questions undertaken to be answered from the written questions of Pharmascience and Apotex by November 15, 2013... filed on 08-NOV-2013

Solicitor's certificate of service on behalf of Amy Grenon confirming service of Doc. 148 and Book of Authorities upon Defendants by personal service on 05-NOV-2013 filed on 05-NOV-2013

Book of Authorities consisting of 1 volume(s) on behalf of Plaintiffs received on 05-NOV-2013

****** CANCELLED ****** Motion Record containing the following original document(s): 145 146 147 Number of copies received: 2 on behalf of Plaintiffs filed on 05-NOV-2013

****** CANCELLED ****** Written Representations contained within a Motion Record on behalf of Plaintiffs concerning Motion Doc. No. 145 filed on 05-NOV-2013

****** CANCELLED ****** Affidavit of Norman Vojir sworn on 05-NOV-2013 contained within a Motion Record on behalf of Plaintiffs in support of Motion Doc. No. 145 with Exhibits A (confidential) filed on 05-NOV-2013

Notice of Motion contained within a Motion Record on behalf of Plaintiffs returnable (but no hearing date indicated at this time) for an Order permitting GSK to serve and file the Second Further Amended Statement of Defence and Counterclaim and the Third Further Amended Statement of Claim, adding GlaxoSmithKline Intellectual Property (No. 2) Limited as Plaintiff by Counterclaim in file T-14-09 and as Plaintiff in T-2101-09, and amending the style of cause. filed on 05-NOV-2013

Draft Order concerning outcome of CMC held 11-Oct-2013 & amalgamation of existing timetables consented to by all parties (sent to the CMJ on 5-Nov-2013) received on 05-NOV-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 05-NOV-2013 directing that by November 6, 2013, the parties are to provide the draft order regarding the outcome of the case management conference held on October 11, 2013, which was agreed would include all outstanding timelines set by previous Orders or, be the same date, provide their availability on November 7 and 8 for a case management conference to discuss the issues preventing the parties from producing the draft order placed on file on 05-NOV-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 21-OCT-2013 advising that the parties need a few more days to provide a draft order re: the 11-Oct-2013 CMC received on 21-OCT-2013

Letter from GSK dated 18-OCT-2013 advising that the parties need until Monday October 21, 2013 to provide a draft order further to the October 11, 2013 CMC received on 18-OCT-2013

Ottawa 11-OCT-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss amendments to schedule Result of Hearing: The parties will provide a draft order which set out all remaining timelines inlcuding timelines set by previous orders by next week held in chambers by way of Conference Call Duration per day: 11-OCT-2013 from 11:30 to 12:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Apotex Jane Caskey and Jordana Sanft 416-216-4000 representing GSK Carol Hitchman 416-865-8259 representing Pharmascience in T-2101-09 Christopher Tan 416-777-2647 representing Pharmascience in T-643-10 Comments: November 12, 2013 has been set aside for the hearing of refusals motions re: third round discovery Minutes of Hearing entered in Vol. 888 page(s) 372 - 374 Abstract of Hearing placed on file

Letter from Apotex dated 10-OCT-2013 providing a proposed schedule to be discussed at the CMC on 11-Oct-2013 (sent to the CMJ on 11-Oct-2013) received on 11-OCT-2013

Letter from GSK dated 09-OCT-2013 advising that the parties are discussing alternative dates for the discovery of GSK's representative (brought to the CMJ's attention on 10-Oct-2013) received on 10-OCT-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 08-OCT-2013 directing that a CMC by TC will take place on 11-Oct-2013 at 11:30 to discuss required amendments to the operative timetable placed on file on 08-OCT-2013 Confirmed in writing to the party(ies)

Ottawa 08-OCT-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Case Management Conference to discuss the scope of the third round discovery Result of Hearing: The Court gives the parties instructions on scope of discovery. A CMC is scheduled on October 11, 2013 to discuss amendments to the schedule. The Court requested a draft order from counsel for Pharmascience in T-643-10 Mr. Sprigings requested costs and the Court indicated that he would include a ruling on costs when issuing the Order re: outcome of this hearing held in Court Senior Usher: S. Young Duration per day: 08-OCT-2013 from 09:30 to 11:55 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 2h30min Appearances: Jerry Topolski and David Scrimger 416-597-5907 representing Apotex Patrick Kierans and Jane Caskey 416-216-4000 representing GSK Warren Sprigings and Christopher Tan 416-777-2647 representing Pharmascience in T-643-10 Minutes of Hearing entered in Vol. 888 page(s) 239 - 246 Abstract of Hearing placed on file

Pharmasciences Responding Submissions received at hearing on 08-OCT-2013

Letter from GSK dated 07-OCT-2013 providing a status report to the Court per Order of 24-Apr-2013 received on 08-OCT-2013

Covering letter from counsel for GSK dated 07-OCT-2013 concerning GSK's Responding Brief placed on file on 07-OCT-2013

Solicitor's certificate of service on behalf of GSK confirming service of their Responding Brief upon all parties by e-mail on 07-OCT-2013 filed on 08-OCT-2013

GSK's Responding Brief for use at the Case Management Conference scheduled to take place on 8-Oct-2013 received on 07-OCT-2013

Sealed envelope pursuant to the Confidentiality Order dated 12-Jan-2011 on behalf of Pharmascience et al. purporting to contain their Brief for use at the Case Management Conference scheduled to proceed on 8-Oct-2013 Received on 04-OCT-2013

Solicitor's certificate of service on behalf of Jesse Todres confirming service of GSK's Brief upon all parties by e-mail on 04-OCT-2013 filed on 08-OCT-2013

GSK's Brief for use at the in person Case Management Conference scheduled to take place in Ottawa on 8-Oct-2013 received on 04-OCT-2013

Letter from counsel for Apotex dated 03-OCT-2013 advising that since there was already a trial management conference in these matters and another one is scheduled on 8-Oct-2013 that the requirement of par. 1(e) of the Order dated 24-Apr-2013 re: requisitioning a TMC is no longer required. (I e-mailed the partie to confirm that Mr. Topolski's assumption is correct; no neet to request a TMC received on 03-OCT-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 02-OCT-2013 directing that (further to Apotex's correspondence dated 1-Oct-2013) the proposed timetable is fine, but two notes: final arguments must be finished by March 20; if this is an issue, we will have to start the trial earlier; otherwise, if counsel are agreed, we'll reserve the January 10th date as the start date. Counsel are to confirm agreement and a direction will issue accordingly placed on file on 02-OCT-2013 Confirmed in writing to the party(ies)

Letter from Apotex on consent of all the parties dated 01-OCT-2013 advising the Trial Judge that a resolution has been reached with respect to the order of presentation of the various issues raised in the actions and the timing of the trial which renders adjudication by the Court unnecessary (sent to the Trial Judge electronically on 02-Oct-2013) received on 01-OCT-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 01-Oct-2013 placed on file on 01-OCT-2013

Written directions received from the Court: The Honourable Mr. Justice Manson dated 01-OCT-2013 directing that A Case Management Conference will take place, in person, in Ottawa on October 8, 2013 at 9:30 a.m. Any submissions, productions or documents the parties want the Court to consider for the October 8, 2013 Case Management Conference are to be submitted electronically at the CMT e-mail address (or hard copies in Ottawa) by 2:00 p.m. on October 4, 2013. Further discovery of Mr. Vojir will proceed on October 17 and 18, 2013. placed on file on 01-OCT-2013 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 27-Sep-2013 placed on file on 27-SEP-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 27-SEP-2013 directing that GSK's request that the third round discovery scheduled to take place on October 2 and 3, 2013 and the case management conference scheduled September 30 be adjourned is granted. The fact that there are some 4000 questions raised in what is supposed to be a limited third round of discovery is unacceptable. Proportionality is completely missing. I direct that Pharmascience and Apotex reconsider and limit the questions to be answered. By 5:00 p.m. September 30, 2013, the parties will advice when the re-attendance for discovery can be held during the week of October 14, 2013. By the same date theparties will provide their availability for an in person case management conference, in Ottawa, during the week of October 7, 2013 (except October 10, 2013) placed on file on 27-SEP-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 27-SEP-2013 requesting a direction adjourning the discovery scheduled to take place on October 2 and 3, 2013 and the CMC by TC scheduled on 30-Sep-2013 to be rescheduled as an in person CMC received on 27-SEP-2013

Acknowledgment of Receipt received from both parties with respect to the direction of the Court dated 25-Sep-2013 placed on file on 25-SEP-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 25-SEP-2013 directing that a case management teleconference is scheduled to take place on September 30, 2013 at 10:00 a.m. to discuss the issues raised in the parties' correspondence dated September 23 and 24, 2013 placed on file on 25-SEP-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 25-SEP-2013 re: the parties' correspondence dated September 23 and 24

Letter from Pharmascience dated 24-SEP-2013 submitting that a CMC on issues with discoveries is premature at this time received on 24-SEP-2013

Letter from GSK dated 23-SEP-2013 advising of issues with respect to further examination for discovery and requesting a CMC to address these issues in advance of the examamination for discovery received on 23-SEP-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 18-Sep-2013 placed on file on 20-SEP-2013

Written directions received from the Court: The Honourable Mr. Justice Manson dated 18-SEP-2013 directing that 1. All parties will serve and file their amended pleadings by September 6, 2013; 2. Counsel for Pharmascience et al. and Apotex will deliver to counsel for GSK et al. questions that will be asked of Mr.Vojir by September 19, 2013; 3, Counsel for GSK et al. will make Mr. Vojir available to be examined for 2 days during the week of September 30, 2013, subject to his availability; 4. All parties will serve and file trial charts by November 8, 2013; 5. All parties will serve and file claims charts by November 29, 2013; and 6. The Court has reserved on the issue of the order of trial issues until after the filing of the trial charts, and will issue an order regarding this matter during the week of November 11, 2013. placed on file on 18-SEP-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 16-SEP-2013 re: (to Manson J. by e-mail) draft direction and trial management conference minutes

Minutes of Trial Management Conference received on 13-SEP-2013

Draft Direction concerning Trial Management Conference received on 13-SEP-2013

Solicitor's certificate of service on behalf of Amy Grenon confirming service of doc 141 upon Defendant by telecopier on 06-SEP-2013 filed on 06-SEP-2013

Further Amended reply and defence to counterclaim filed on 06-SEP-2013

Affidavit of service of Danielle Murphy sworn on 06-SEP-2013 on behalf of Defendant confirming service of doc. #139 upon Plaintiff by personal service on 05-SEP-2013 filed on 06-SEP-2013

Amended (Second Amended) Statement of Defence and Counterclaim filed on 06-SEP-2013

Affidavit of service of Leo Pereira sworn on 05-SEP-2013 on behalf of Plaintiff confirming service of doc 136 upon Sprigings LLP by process server on 05-SEP-2013 filed on 05-SEP-2013

Affidavit of service of Heather Johnson sworn on 05-SEP-2013 on behalf of Plaintiff confirming service of doc 136 upon Gardiner Roberts LLP by process server on 05-SEP-2013 filed on 05-SEP-2013

Further Amended Statement of Claim filed on 05-SEP-2013

Toronto 03-SEP-2013 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Trial Management Conference Result of Hearing: On Consent of counsel for the parties, the Court determines the following steps to be complete: 1. Further Amended Pleadings shall be served and filed by September 6, 2013. 2. Apotex and Pharmascience shall provide their questions in writing to Glaxosmithkline by September 19, 2013. Cross-examinations of the GSK representative shall be conducted during the week of September 30, 2013. 4. Each party shall file a Trial schedule by November 8/13. 5. Claim Charts shall be filed by November 29/13. held ADR Senior Usher: Anne Brzuchalski Duration per day: 03-SEP-2013 from 03:00 to 04:00 Courtroom : Conference Room No. 5-43 - Toronto Court Registrar: Mary Sansone Total Duration: 1h Appearances: Patrick Kierans, Jane Caskey, Jordana Sanft 416 216-4000 representing Plaintiff Warren Sprigings, Christopher Tan 416 777-2647 representing Defendants Comments: Heard together with T-14-09 and T-643-10. See T-14-09 for full Minutes of Hearing Minutes of Hearing entered in Vol. 885 page(s) 466 - 468 Abstract of Hearing placed on file

Acknowledgment of Receipt received from GSK and PMS with respect to Madam Aronovitch's direction dated 21-Aug-2013 placed on file on 21-AUG-2013

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 21-AUG-2013 directing that the mediation that was scheduled to be heard November 18-21 has been rescheduled to November 13-15. placed on file on 21-AUG-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 21-AUG-2013 directing that as there is no agreement between the parties and a Direction has not issued, parties are to refer the matters in dispute to Justice Manson. The contentious issues could only be dealt with by Direction, if with the guidance I provided, parties were able to come to some agreement. Failing agreement, the dispute will likely require a motion placed on file on 21-AUG-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 20-AUG-2013 advising that the parties are unable to agree on the oral direction given by Madam Aronovitch at the CMC on August 6, 2013 (sent to Madam Aronovitch on 21-Aug-2013) received on 21-AUG-2013

Memorandum to file from Julie Dulac dated 16-AUG-2013 the parties were advised that they may submit their proposed timetable on 20-Aug-2013 placed on file.

Letter from GSK dated 15-AUG-2013 requesting an extension of time until August 20th to submit a schedule for the service and filing of the amended pleadings and written discovery received on 15-AUG-2013

Acknowledgment of Receipt received from all parties with respect to the direction of Manson J. dated 9-Aug-2013 placed on file on 09-AUG-2013

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 09-AUG-2013 directing that a CMC/Trial Management Conference is scheduled, in person, in Toronto on September 3, 2013 at 3:00 p.m. placed on file on 09-AUG-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 09-AUG-2013 re: (to Manson J. by e-mail) GSK's letter dated 8-Aug-2013

Letter from GSK dated 08-AUG-2013 providing the parties' availability for a CMC/trial management conference with Mr. Justice Manson received on 08-AUG-2013

Ottawa 06-AUG-2013 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the parties will provide their availability for a CMC/ trial management conference with Manson J. by August 8th. They will provide a draft amended timetable by August 15th held in chambers Duration per day: 06-AUG-2013 from 11:00 to 11:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: David Scrimger and Jenene Roberts 416-597-6262 representing Apotex Jordana Sanft 416-317-4613 representing GSK Jane Caskey 416-458-9840 representing GSK Daniel Daniele 416-216-2317 representing GSK Carol Hitchman and Alisse Houweling 416-865-8259 representing PMS in T-2101-09 Christopher Tan and Warren Sprigings 416-777-2647 representing PMS in T-643-10 Minutes of Hearing entered in Vol. 884 page(s) 479 - 480 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 02-AUG-2013 re: Preparation of the file for the case confernece on August 6, 2013

Letter from GlaxoSmithKline dated 02-AUG-2013 in response to the letter from Mr. Tan dated July 29, 2013 received on 02-AUG-2013

Letter from Pharmascience dated 01-AUG-2013 Providing the Court with a status report received on 01-AUG-2013

Letter from Pharmascience dated 29-JUL-2013 reqeusting that the issues in letter be discussed at the case conference on August 6, 2013 received on 29-JUL-2013

Letter from Plaintiffs (GlaxoSmithKline) dated 31-JUL-2013 providing the court with dates of availability to continue the mediation received on 31-JUL-2013

Oral directions received from the Court: Chief Justice Crampton dated 29-JUL-2013 directing that Madam Prothonotary Aronovitch will be on sabbatical from August 16, 2013 to December 30, 2013. In her absence, Mr. Justice Manson is hereby assigned as case management judge in respect to the above noted file. Parties are to continue to send draft orders, directions and correspondence to cmt_ottawa@cas-satj.gc.ca. placed on file on 29-JUL-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 29-JUL-2013 directing that There will be a case management confernece, by teleconference on August 6, 2013, for one hour, commencing at 11:00 placed on file on 29-JUL-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 29-JUL-2013 re: by email informing the Court of the dates of availability of the parties to attend a CMC

Memorandum to file from Annette Houle, Ottawa dated 29-JUL-2013 parties provided their availability for a CMC. The parties are available after 2:00 on July 30, 2013 and all day on August 6, 2013. placed on file.

Copy of Oral Direction dated 22-JUL-2013 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-14-09

Communication to the Court from the Registry dated 12-JUL-2013 re: the requisition for PTC and Apotex's letter dated 28-Jun-2013 providing a status of mediation

Letter from Apotex dated 28-JUN-2013 giving the CMJ and update re: mediation process received on 28-JUN-2013

Copy of Letter dated 2-JUL-2013 on behalf of Plaintiff placed on file on 02-JUL-2013 Original filed on Court File No. T-14-09

Copy of Request for PTC on behalf of Plaintiff placed on file on 28-JUN-2013 Original filed on Court File No. T-14-09

Toronto 27-JUN-2013 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the Mediation scheduled for 5-8-Nov, 2013 is re-scheduled to nov 18-21, 2013 at 10:00am. A case management conference will be held Nov. 4 at 10:00am, Parties are to send mediation material(minus exhibits) to Court. held in chambers Duration per day: 27-JUN-2013 from 10:00 to 10:35 Courtroom : Judge's Chambers - Toronto Court Registrar: Jacqueline Smith Total Duration: 35min Appearances: Ms Jane Caskey 416-216-4000 representing Plaintiff Ms Jordana Sanft 416-216-4000 representing Plaintiff Mr. Warren Sprigings 416-777-2273 representing Defendant Mr. Christopher Tan 416-777-2273 representing Defendant Minutes of Hearing entered in Vol. 883 page(s) 197 - 198 Abstract of Hearing placed on file

Status report on behalf of Apotex (sent to the CMJ on 10-Jun-2013) received on 07-JUN-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 3-Jun-2013 placed on file on 05-JUN-2013

Copy of Letter from Norton Rose Fulbright Canada LLP / s.e.n.c.r.l., s.r.l. dated 13-MAY-2013. re: Change of company name. Copy placed on 62 files. placed on file on 29-MAY-2013 Original placed on Court File No. T-2022-89

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 03-JUN-2013 directing that parties are to advise the case management judge of the dates fixed for further settlement conferences within a week of the dates having been fixed placed on file on 03-JUN-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 30-MAY-2013 pursuant to paragraph 2 of the Order dated April 24, 2013 (sent to CMJ on 31-May-2013) received on 31-MAY-2013

Acknowledgment of Receipt received from all parties with respect to the Order of the Court (Snider J.) dated May 13, 2013 placed on file on 14-MAY-2013

Order dated 13-MAY-2013 rendered by The Honourable Madam Justice Snider Matter considered with personal appearance The Court's decision is with regard to Trial Management Conference Result: 1. The deadline provided for in subparagraph 1(a) of the scheduling Order is hereby amended to read May 22, 201.; and 2. The deadline provided for in subparagraph 1(d) of the Scheduling Order is hereby amended to read October 21, 2013. Filed on 13-MAY-2013 entered in J. & O. Book, volume 1192 page(s) 452 - 454 Interlocutory Decision

Toronto 13-MAY-2013 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Mediation scheduled for 28-31 May 2013, has been adjourned.A Case Management Conference will be held 27-jun-2013 at 10am, Mediation scheduled 5-8 Nov, 2013, Expert reports(text only) to be submitted for the Mediation. held in camera Duration per day: 13-MAY-2013 from 10:30 to 11:20 Courtroom : Judge's Chambers - Toronto Court Registrar: Jacqueline Smith Total Duration: 50min Appearances: Ms Jane Caskey 416-216-4000 representing Plaintiff Ms Jordana Sanft 416-216-4000 representing Plaintiff Mr. Warren Sprigings 416-777-2273 representing Defendant Mr Ken Crofoot 416-597-6262 representing Defendant Minutes of Hearing entered in Vol. 880 page(s) 363 - 364 Abstract of Hearing placed on file

Draft Order concerning the Trial Management Conference held on May 9, 2013. received on 10-MAY-2013

Ottawa 09-MAY-2013 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Trial Management Conference Result of Hearing: Extension of 1 week granted. Mr. Topolski to send a draft order the Court held by way of Conference Call Duration per day: 09-MAY-2013 from 01:30 to 01:45 Courtroom : Judge's Chambers - Ottawa Court Registrar: Benoit Labelle Total Duration: 15min Appearances: Mr. Jerry Topolski (416) 597-5907 representing Plaintiff Ms. Jordana Sanft, Ms.Jane Caskey, Mr. Patrick Kearns (416) 216-4798 representing GlaxosmithKline Mr. Christopher Tan and Mr. Warren Sprigings (416) 777-0888 representing Pharmascience in T-643-10 Ms. Alisse Houwelling (416) 865-6600 representing Pharmascience in T-2101-09 Comments: Heard with T-14-09 and T-643-10. Minutes of hearing on T-14-09. Minutes of Hearing entered in Vol. 880 page(s) 254 - 255 Abstract of Hearing placed on file

Letter from Apotex dated 08-MAY-2013 requesting an urgent trial management conference to discuss an extension of time to deliver expert reports which are due 15-May-2013 received on 08-MAY-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 7-May-2013 placed on file on 07-MAY-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 07-MAY-2013 directing that in light of correspondence from GSK and Apotex dated May 6, 2013, respectively, parties are advised to request a teleconference with Snider J. to deal with the request for an extension. The case management conference fixed for 3:00 p.m. today is accordingly adjourned sine die placed on file on 07-MAY-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 06-MAY-2013 in reply to GSK's letter of 6-May-2013 (given to the CMJ on 7-May-2013 at 9:30) received on 07-MAY-2013

Letter from GSK dated 06-MAY-2013 in response to Apotex's letter of 2-May-2013 (given to the CMJ on May 7, 2013 at 9:30 a.m.) received on 06-MAY-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 03-MAY-2013 directing that a case management teleconference will take place on May 7, 2013 at 3:00 p.m. GSK shall serve and file a response to Apotex's correspondence dated May 2, 2013, if any, by May 6, 2013. placed on file on 03-MAY-2013 Confirmed in writing to the party(ies)

Letter from Apotex dated 02-MAY-2013 requesting a CMC to discuss issues that arose which are going to make it difficult to complete their expert reports (sent to CMJ on 3-May-2013) received on 02-MAY-2013

Acknowledgment of Receipt received from all parties with respect to the decision of the Court dated 24-Apr-2013 placed on file on 25-APR-2013

Order dated 24-APR-2013 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from defendants dated 17-APR-2013 Result: consolidated timetable is established Filed on 24-APR-2013 copies sent to parties entered in J. & O. Book, volume 1191 page(s) 126 - 131 Interlocutory Decision

Draft Order concerning direction of the Court dated 4-Mar-2013 and letter dated 17-Apr-2013 received on 19-APR-2013

Communication to the Court from the Registry dated 18-APR-2013 re: ID 520

Letter from Defendants dated 17-APR-2013 providing a consolidated timetable per the direction of March 4, 2013 received on 17-APR-2013

Minutes of Trial Management Conference received on 03-APR-2013

Acknowledgment of Receipt received from all parties with respect to Doc. #133 (Order of Aronovitch P., dated March 21, 2013) placed on file on 21-MAR-2013

Order dated 21-MAR-2013 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 127 Result: THIS COURT ORDERS that: 1. GSK shall supply written answers to the questions they have agreed to answer in accordance with Schedule 'A', Schedule 'B' and Schedule 'C' to this Order by March 31, 2013; and 2. There will be no costs of this motion. Filed on 21-MAR-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1187 page(s) 308 - 318 Interlocutory Decision

Acknowledgment of Receipt received from all parties by email with respect to the Direction of the Court (Snider J.) dated March 21, 2013. placed on file on 21-MAR-2013

Oral directions received from the Court: The Honourable Madam Justice Snider dated 21-MAR-2013 directing that "The Court is amenable to receiving the Trial Record on November 22, 2013." placed on file on 21-MAR-2013

Draft Order relating to Motion Doc. No. 127 approved as to form and content by all parties (sent to the CMJ on 20-Mar-2013) received on 19-MAR-2013

Letter from Defendant dated 14-MAR-2013 Advising that parties consent to the submission of trial records on November 22, 2013, and asking whether this is acceptable to the Court. received on 14-MAR-2013

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Written Directions of the Court dated 4-MAR-2013 placed on file on 04-MAR-2013

Toronto 04-MAR-2013 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Trial Management Conference Result of Hearing: the trial of files T-643-10 & T-2101-09 will take place Jan. 7/14 in Toronto The Pharmascience trials shall be consolodated with the trial of T-14-09. The consolodated trial will will continue for a duration of 40 days. held in Court Duration per day: 04-MAR-2013 from 03:30 to 04:35 Courtroom : Conference Room No. 5-43 - Toronto Court Registrar: Michael Pace Total Duration: 1h 5min Appearances: Patrick Kierans 416-216-3904 representing GSK Jane Caskie 416-216-1925 representing GSK Jordana Sanft 416-216-1925 representing GSK Daniel Daniele 416-216-1925 representing GSK Carole Hitchman 416-865-8259 representing Pharmascience Alissa Houweling 416-865-8259 representing Pharmascience Warren Spriggings 416-777-0888 representing Pharmascience Christopher Tan 416-777-0888 representing Pharmascience David Scrimger 416-597-6262 representing Apotex Ken Crowfoot 416-979-2211 representing Apotex Comments: Mr. Daniel Daniele took minutes for counsel. Minutes for the Court on files T-2101-09, T-643-10 and T-14-09 can be found with T-2101-09 Mr. Charles Kinzig (VP for GSK) sat in the conference. Minutes of Hearing entered in Vol. 876 page(s) 291 - 293 Abstract of Hearing placed on file

Acknowledgment of Receipt received from the Parties via email with respect to Doc 132 placed on file on 05-MAR-2013

Communication to the Court from the Registry dated 20-FEB-2013 re: consolidated timetable of steps further to the Direction of the Court 4-FEB- 2013

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 04-MAR-2013 directing that "The parties are to resubmit a consolidated timetable after March 4, 2013 including: 1. The fixing of trial date for the three actions and the number of days for trial 2. A timetable for status reports 3. Dates for the filing of trial records after confirmation by Justice Snider 4. A fixed date by which parties will request a trial management conference 5. A mechanism for reporting on the date of any further settlement conferences and reporting to the Court thereafter." placed on file on 04-MAR-2013 Confirmed in writing to the party(ies)

Order dated 05-MAR-2013 rendered by The Honourable Madam Justice Snider Matter considered with personal appearance The Court's decision is with regard to Trial Management Conference Result: 1) The joint trial of Court File Nos. T-643-10 & T-2101-09 shall take place 07-JAN-2014 in Toronto. 2) The Pharmascience trials shall be consolidated with the trial of T-14-09. 3) The consolidated trial will continue for a duration of: (a) no longer than 40 sitting days for the evidentiary portion of the trial; (b) no longer than five sitting days for final argument. 4) A copy of this Order shall be placed on T-14-09. Filed on 05-MAR-2013 certified copies sent to parties entered in J. & O. Book, volume 1186 page(s) 1 - 3 Interlocutory Decision

Oral directions received from the Court: The Honourable Madam Justice Snider dated 28-FEB-2013 directing that the TMC originally scheduled for March 4 /13 at 3:00 pm is now scheduled for 3:30 Monday March 4 /13. placed on file on 28-FEB-2013

Draft Order concerning letter of February 15, 2013 (sent up to the CMJ on 20-Feb-2013) received on 19-FEB-2013

Letter from counsel for PMS dated 15-FEB-2013 providing a consolidated timetable on consent as required by the direction of the Court dated 4-Feb-2013 received on 15-FEB-2013

Oral directions received from the Court: The Honourable Madam Justice Snider dated 13-FEB-2013 directing that "A Trial Management Conference will take place March 4, 2013 in Toronto in person at 3 pm, for a duration of no later than 2 hours." placed on file on 13-FEB-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 11-FEB-2013 requesting a trial management conference further to the direction of Madam Aronovitch dated 4-Feb-2013 Letter scanned to Trial Judge's attention. received on 11-FEB-2013

Letter from GSK dated 08-FEB-2013 providing a status report as required by par. 8(a) of the May-25-2012 Order (sent to the CMJ on 11-Feb-2013) received on 08-FEB-2013

Acknowledgment of Receipt received from All parties with respect to the Oral Directions (2) from Aronovitch, P. dated February 4, 2013. placed on file on 04-FEB-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 04-FEB-2013 directing that "Re: Correspondence on behalf of GSK dated January 30, 2013, requesting and extension of time until June 28, 2013 to serve and file its request for PTC Granted. In light of the trial of the three actions in January 2014, by February 15, 2013, parties are to file one consolidated revised timetable of further steps in the three actions." placed on file on 04-FEB-2013 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 04-FEB-2013 directing that "Re: Correspondence on behalf of GSK dated January 28, 2013 and on behalf of Apotex and Pharmascience dated February 1, 2013. By February 11, 2013, parties are to jointly request a trial management conference with Justice Snider to fix the length of the trial of the three actions starting on January 13, 2014." placed on file on 04-FEB-2013 Confirmed in writing to the party(ies)

Memorandum to file from Julie Dulac dated 04-FEB-2013 the parties' correspondence dated 28-Jan-2013 and 1-Feb-2013 submitted by the parties in compliance with the Court's direction dated 25-Jan-2013 was given to the CMJ today placed on file.

Letter from PMS in T-643-10 on their's and PMS in T-2101-09 and Apotex's behalf dated 01-FEB-2013 providing submissions further to the Court's direction dated 25-Jan-2013 received on 01-FEB-2013

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 30-Jan-2013 placed on file on 31-JAN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 30-JAN-2013 directing that further to Mr. Tan's letter of 28-Jan-2013 requesting an extension of time to comply with the direction of the Court dated 25-Jan-2013 the request is granted placed on file on 30-JAN-2013 Confirmed in writing to the party(ies)

Letter from GSK dated 30-JAN-2013 requesting an extension of time until June 28, 2013 to serve and file a request for PTC received on 30-JAN-2013

Communication to the Court from the Registry dated 29-JAN-2013 re: the parties' correspondence dated 28-Jan-2013

Letter from counsel for PMS in T-643-10 dated 28-JAN-2013 writing on their behalf and on behalf of counsel for PMS in T-2101-09 and counsel for Apotex in T-14-09 requesting an extension of time to comply with the Court's direction dated 25-Jan-2013 received on 28-JAN-2013

Letter from GSK dated 28-JAN-2013 in response to the Court's direction dated 25-Jan-2013 received on 28-JAN-2013

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated January 24, 2013. placed on file on 25-JAN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 24-JAN-2013 directing that "Re: Trial Dates: T-2101-09, T-643-10, T-14-09 It is my understanding that in the course of a mediation of the issues in the above-noted actions, held in December 2012, the parties reached an agreement to vacate the dates for the trial of the actions in T-2101-09 and T-643-10, set down for hearing for 40 days commencing on September 9, 2013, before Justice Snider, and instead, have agreed to have the trial of the three actions proceed together on the basis of consolidated expert evidence, before Justice Snider, on January 13, 2014, for 25 days, being the dates fixed for the trial of T-14-09 alone. Before the September dates can be vacated, the parties will have to confirm the above-noted agreement, and that the 25 days set aside in January will suffice for the trial of the three actions. Parties are reminded that the 40 days in September had included consideration of time needed for simultaneous translation. Parties are to confirm, or comment, including as to the sufficiency of the 25 days, by no later than January 28, 2013." placed on file on 24-JAN-2013 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from All parties with respect to the Written Direction of Aronovitch, P. dated January 23, 2013. placed on file on 24-JAN-2013

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 23-JAN-2013 directing that The continuation of the second round of motions to compel, previously ordered to take place in Ottawa on January 9, 10 and 11, 2013, has been adjourned to commence on March 5, 2013, at 10:00 a.m. in Ottawa. Pharmascience and Apotex's motion to compel answers from the second round of discovery of Dr. Krenitsky in Court File Nos. T-14-09, T-2101-09 and T-643-10 in respect of scientific issues shall be heard first for 1.5 days on March 5 and 6, 2013. GSK's motion to compel answers from the second round of discovery of Ms. Ship (Pharmascience) in Court File No. T-643-10 in respect of financial issues shall be heard second on March 6, 2013, for half a day. placed on file on 24-JAN-2013 Confirmed in writing to the party(ies)

Letter from PMS dated 16-JAN-2013 attaching a draft direction further to the CMC which took place on 11-Jan-2013 sent up to the CMJ on 17-Jan-2013 received on 16-JAN-2013

Ottawa 11-JAN-2013 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the rescheduling of the refusals motions originally scheduled to take place on January 9, 10 and 11, 2013 but adjourned Result of Hearing: the refusals motions will be heard on March 5 and 6, 2013 in Ottawa. Ms. Hitchman will provide a draft direction by January 16, 2013. The timelines to exchange expert reports was extended to same timelines as T-14-09 held by way of Conference Call in chambers Duration per day: 11-JAN-2013 from 10:25 to 10:55 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jordana Sanft and Keith Aguilera 416-216-1925 representing Plaintiffs Carol Hitchman and Alisse Houweling 416-865-8259 representing Defendants Minutes of Hearing entered in Vol. 873 page(s) 450 - 453 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 8-Jan-2013 placed on file on 08-JAN-2013

Letter from GSK dated 09-JAN-2013 requesting that the refusals motion which were scheduled to take place on January 9 to 11, 2013 and adjourned, be rescheduled during the week of January 14th, 2013 received on 09-JAN-2013

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 08-JAN-2013 directing that a case management teleconference will take place on Friday January 11, 2013 at 10:00 a.m. to discuss the rescheduling of the refusals motions originally scheduled to take place on January 9, 10 and 11, 2013 and now adjourned placed on file on 08-JAN-2013 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 20-Dec-2012 placed on file on 21-DEC-2012

Acknowledgment of Receipt received from all parties with respect to Order doc. nos. 130 and 131 placed on file on 24-DEC-2012

Order dated 21-DEC-2012 rendered by Roza Aronovitch, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 129 Result: granted in part Filed on 21-DEC-2012 Transmittal Letters placed on file. entered in J. & O. Book, volume 1179 page(s) 152 - 161 Interlocutory Decision

Order dated 21-DEC-2012 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 110 Result: granted in part Filed on 21-DEC-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1179 page(s) 148 - 151 Interlocutory Decision

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 20-DEC-2012 directing that the plaintiffs in T-2101-09 and T-643-10 are granted an extension of time until January 31, 2013 to serve and file a request for pre-trial conference placed on file on 20-DEC-2012 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 20-DEC-2012 directing that the motion set down for hearing in Ottawa on December 21, 2012 is hereby adjourned to be heard in Ottawa on January 9, 2013 commencing at 9:30 a.m. for 4 hours. PMS and Apotex's motion to compel GSK (Dr. Krenitsky) is scheduled to be heard in Ottawa for 1.5 days commencing on January 10, 2013 at 9:30 a.m. placed on file on 20-DEC-2012 Confirmed in writing to the party(ies)

Draft Order concerning Motion Doc. No. 110 consented to by all parties received on 20-DEC-2012

Draft order on consent concerning Motion Doc. No. 129 received on 20-DEC-2012

Letter from GSK dated 17-DEC-2012 advising of remaining questions for adjudication on 21-Dec-2012 (communicated to the CMJ on 17-Dec-2012) received on 17-DEC-2012

Communication to the Court from the Registry dated 17-DEC-2012 re: PMS's letter dated 7-Dec-2012 providing a status report and requesting an extension of time to provide a draft order re: refusals and GSK's letter dated 13-Dec-2012

Letter from GSK dated 14-DEC-2012 requesting an extension of time until January 31, 2013 to serve and file a request for pre-trial conference received on 14-DEC-2012

Toronto 10-DEC-2012 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Mediation Result of Hearing: Matter adjourned sine die held in Court Senior Usher: Anne Street 10-DEC-2012 Anne Street 11-DEC-2012 Anne Street 12-DEC-2012 Duration per day: 10-DEC-2012 from 10:00 to 04:30 Courtroom : Conference Room No. 7-39 - Toronto Court Registrar: Jacqueline Smith 11-DEC-2012 from 09:30 to 04:50 Courtroom : Conference Room No. 7-39 - Toronto Court Registrar: Jacqueline Smith 12-DEC-2012 from 10:00 to 12:50 Courtroom : Conference Room No. 7-39 - Toronto Court Registrar: Jacqueline Smith Total Duration: 2.5d Appearances: Ms Jane Caskey 416-216-3930 representing Plaintiff Ms. Jordana Sanft 416-216-3930 representing Plaintiff Mr. Warren Sprigings 416-777-0888 representing Defendant Mr. Christopher Tan 416-777-0888 representing Defendant Minutes of Hearing entered in Vol. 872 page(s) 309 - 310 Abstract of Hearing placed on file

Letter from Pharmascience dated 07-DEC-2012 write on behalf of counsel for defendants in T-2101-09 and for GSK. We request extension of deadline to file orders from motions to compel until December 19,2012. received on 07-DEC-2012

Letter from Plaintiff dated 07-DEC-2012 Update report on above proceedings provided in paragraph 8(9) Order dated May 25,2012, for the attention of Prothonotary Aronovitch. received on 07-DEC-2012

Covering letter from GSK dated 19-NOV-2012 concerning Doc. Nos. 127 129 placed on file on 19-NOV-2012

Ottawa 28-NOV-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 110 on behalf of GSK Result of Hearing: Matter partially granted Before the Court: Motion Doc. No. 129 on behalf of PMS Result of Hearing: Matter partially granted held in Court Senior Usher: S. Young Duration per day: 28-NOV-2012 from 10:00 to 11:45 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac 29-NOV-2012 from 09:30 to 05:05 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac 30-NOV-2012 from 09:30 to 03:20 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 2d Appearances: Keith Aguilera and William Pellerin 416-216-1925 representing GSK Christopher Tan and Patrick Hui 416-777-2647 representing PMS (on behalf of Gardiner Roberts just for today) Draft Decision to be submitted by both parties Minutes of Hearing entered in Vol. 872 page(s) 48 - 49 Abstract of Hearing placed on file

Notice of Motion on behalf of PMS and Apotex returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling GSK(Cindy Roll and Norman Vojir)(full motion record only filed in T-14-09 doc no. 76 along with joint brief of relevant documents doc 77) (sealed per protective order dated 29-Jun-2011) filed on 19-NOV-2012

Memorandum to file from Julie Dulac dated 28-NOV-2012 the document required by the direction of the Court dated 27-Nov-2012 was placed in a sealed envelope in T-14-09 only placed on file.

Acknowledgment of Receipt received from all parties with respect to the Oral Direction of Aronovitch P., dated November 27, 2012 placed on file on 27-NOV-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 27-NOV-2012 directing that "Plaintiffs are to make preliminary submissions in writing, in point the corporate plaintiffs, their respective roles in the manufacture, promotion and sale of valacyclovir, in Canada. Any agreements of the parties that relate to the above are to be noted by reference to the production found in the joint book of documents, which is to include a brief description of the nature of the document." placed on file on 27-NOV-2012 Confirmed in writing to the party(ies)

Ottawa 22-NOV-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the Court decided on the order in which the motions are going to be heard on 28-Nov-2012 held in chambers by way of Conference Call Duration per day: 22-NOV-2012 from 10:00 to 10:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 20min Appearances: Jordana Sanft and Keith Aguilera 416-216-4798 representing GSK Carol Hitchman 416-865-8259 representing PMS et al Minutes of Hearing entered in Vol. 871 page(s) 278 - 279 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Rosamaria Longo confirming service of doc. 127 upon Plaintiffs by e-mail on 06-NOV-2012 filed on 19-NOV-2012

Notice of Motion on behalf of Defendants returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling anwers from GSK re: examination of Dr. Krenitsky (sealed per protective order 29-Jun-2011)(complete motion record only filed in T-14-09 under doc. 73) filed on 19-NOV-2012

Letter from Defendants dated 22-NOV-2012 advising that 65 questions need adjudication in motion to compel GSK re: Dr. Krenitsky received on 22-NOV-2012

Covering letter from PMS dated 19-NOV-2012 concerning Doc. Nos. 112 113 116 117 120 121 124 125 placed on file on 19-NOV-2012

Solicitor's certificate of service on behalf of Christopher Tan confirming service of docs 112,113 116,117,120,121,124,125 upon GSK by personal service on 19-NOV-2012 filed on 19-NOV-2012

Aide-memoire re: motion doc 122 (sealed)(only one copy for the judge) filed on 19-NOV-2012

Motion Record containing the following original document(s): 123 Number of copies received: 2 on behalf of Defendants (whole document is sealed) filed on 19-NOV-2012

5 column chart re: motion doc. 122 filed on 19-NOV-2012

Notice of Motion contained within a Motion Record on behalf of GSK returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling Laboratoire Riva Inc. (Olivier St-Denis) filed on 19-NOV-2012

Aide-memoire re: motion record doc. 120(sealed)(only one copy for the Judge) filed on 19-NOV-2012

Motion Record containing the following original document(s): 119 Number of copies received: 2 on behalf of Defendants (whole document sealed) filed on 19-NOV-2012

5 column chart re: motion doc. 118 filed on 19-NOV-2012

Notice of Motion contained within a Motion Record on behalf of GSK returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling Dominion Pharmacal (Debbie Ship) filed on 19-NOV-2012

Aide-Memoire re: motion record doc. 116 (sealed)(only one copy filed for the Judge) filed on 19-NOV-2012

Motion Record containing the following original document(s): 115 Number of copies received: 2 on behalf of Defendants (whole document is sealed) filed on 19-NOV-2012

5 column chart re: motion doc 114 filed on 19-NOV-2012

Notice of Motion contained within a Motion Record on behalf of GSK returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling Pro-Doc Limitée (Marcel Raymond) filed on 19-NOV-2012

Aide-memoire re: motion record doc. no. 112 (sealed)(only one copy filed for Judge) filed on 19-NOV-2012

Motion Record containing the following original document(s): 111 Number of copies received: 2 on behalf of Defendants (whole motion record is sealed) filed on 19-NOV-2012

5 column chart re: motion doc 110 filed on 19-NOV-2012

Notice of Motion contained within a Motion Record on behalf of GSK returnable at Special Sitting in Ottawa on 28-NOV-2012 to begin at 10:00 for an Order compelling PMS Inc. filed on 19-NOV-2012

Ottawa 08-NOV-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss issues raised in correspondence dated November 1, 2 and 6, 2012 Result of Hearing: See abstract in T-14-09 held in chambers by way of Conference Call Duration per day: 08-NOV-2012 from 03:00 to 03:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: Jordana Sanft and Keith Aguilera 416-216-4798 representing GSK Carol Hitchman 416-865-8259 representing PMS Minutes of Hearing entered in Vol. 870 page(s) 376 - 377 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 7-Nov-2012 placed on file on 07-NOV-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 06-NOV-2012 directing that a CMC by TC is scheduled to proceed on 8-Nov-2012 at 3:00 p.m. placed on file on 07-NOV-2012 Confirmed in writing to the party(ies)

Letter from GSK dated 06-NOV-2012 in response to Apotex's letter dated 2-Nov-2012(given to the CMJ on 7-Nov- 2012) received on 06-NOV-2012

Communication to the Court from the Registry dated 02-NOV-2012 re: (verbal communication) GSK's letter of 1-Nov-2012 and Apotex's response dated 2-Nov-2012. The Court asked me to advise GSK that before calling a CMC she would like to hear from GSK in response to Apotex's letter dated 2-Nov-2012

Letter from PMS dated 02-NOV-2012 advising that they take the same position as Apotex in T-14-09 as set out in it's letter dated 2-Nov-2012 received on 02-NOV-2012

Letter from GSK dated 01-NOV-2012 advising that they were served with a Notice of Inter Partes Testing and requesting a CMC so that the issues can be resolved received on 01-NOV-2012

Acknowledgment of Receipt received from parties with respect to doc.#109 placed on file on 29-OCT-2012

MEMORANDUM to CMJ - Aronovitch, P., from S.Mbuyi, Actions Section enclosing certified copy of Reasons for Order and Order doc.#109 of O'Keefe, J. placed on file on 30-OCT-2012

Reasons for Order and Order dated 29-OCT-2012 rendered by The Honourable Mr. Justice O'Keefe Matter considered with personal appearance The Court's decision is with regard to Motion in writing Doc. No. 89 Result: "THIS COURT ORDERS that: 1.The Prothonotary's order is set aside with respect to the following questions in Schedule "C" to the order: Category 1: Items 2, 11, 29 Category 4: Items 68-69, 73, 80-82, 86, 87, 98-99 Category 8: Items 162, 163, 165 2.Pharmascience Inc., Laboratoire Riva Inc., Pro Doc Limitée, Dominion Pharmacal, Zymcan Pharmaceuticals Inc., Pharmel Inc. and Apotex Inc. shall have their costs of the motion." Filed on 29-OCT-2012 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1172 page(s) 307 - 309

Acknowledgment of Receipt received from all parties with respect to the written direction of Aronovitch, P. dated October 19, 2012 placed on file on 19-OCT-2012

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 19-OCT-2012 directing that 1. Second-round motions to compel a) The second-round motions to compel, previously ordered to take place for five days in Toronto commencing on November 26, 2012, are hereby adjourned to commence on November 28, 2012, at 10:00 a.m. in Ottawa. b) The parties' motions in respect of financial issues shall be heard on November 28 and 29, 2012, in Ottawa. c) Apotex and PMS et al.'s motion in respect of scientific issues shall be heard on November 30, 2012, (and if necessary, December 21, 2012) in Ottawa. 2. Motion records for second-round motions to compel The dates for the parties to exchange their moving and responding motion records, previously ordered to occur on October 26 and November 16, 2012, respectively, are hereby amended as follows: a) Moving parties' motion records shall be served by November 2, 2012. b) Responding parties' motion records shall be served and filed, in Ottawa, to the attention of Julie Dulac, by November 19, 2012. placed on file on 19-OCT-2012 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 16-OCT-2012 re: the parties' draft direction rec'd 12-Oct-2012

Draft direction concerning CMC held 9-Oct-2012 consented to by all parties received on 12-OCT-2012

Ottawa 09-OCT-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss changes to the November hearing dates Result of Hearing: Ms. Sanft will prepare a draft order and submit it by Friday October 12, 2012 held in chambers by way of Conference Call Duration per day: 09-OCT-2012 from 03:00 to 03:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 25min Appearances: Jordana Sanft and Keith Aguilera 416-216-4798 representing Glaxo Carol Hitchman 416-865-8259 representing Pharmascience et al Comments: see comments in T-14-09 Minutes of Hearing entered in Vol. 869 page(s) 6 - 7 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to direction dated 2-Oct-2012 placed on file on 02-OCT-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 02-OCT-2012 directing that a case management teleconference will take place on October 9, 2012 at 3:00 p.m. placed on file on 02-OCT-2012 Confirmed in writing to the party(ies)

Copy of Discontinuance on behalf of Appellant dated 14-SEP-2012 placed on file on 25-SEP-2012 Original filed on Court File No. A-293-12

Toronto 14-SEP-2012 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: minutes can be found on T-14-09 held in ADR room Senior Usher: Ken Massey Duration per day: 12-SEP-2012 from 01:00 to 02:00 Courtroom : Discovery Room No. 4-45 - Toronto Court Registrar: Shaun Nelson Total Duration: 1hour Appearances: Ms. Caskey, Ms. Sanft 416-216-1899 representing Plaintiff Mr. Sprigings, Mr. Tan 416-777-2273 representing Defendant Minutes of Hearing entered in Vol. 867 page(s) 426 - 427 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 11-SEP-2012 re: letters of 11-SEP-2012 sent to the court

Letter from GlaxoSmithKline Inc. dated 11-SEP-2012 providing the court with an agenda for the CMC scheduled for 12-SEp-2012 received on 11-SEP-2012

Letter from Pharamascience Inc. dated 11-SEP-2012 providing the court with an agenda for the CMC scheduled for 12-SEP-2012 received on 11-SEP-2012

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 23-AUG-2012 directing that the CMC shall reconvene on 12-SEP-2012 at 1:00 and will be in person placed on file on 23-AUG-2012

Toronto 23-AUG-2012 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: minutes can be found on T-14-09 held in chambers by way of Conference Call Duration per day: 23-AUG-2012 from 01:10 to 01:40 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 30min Appearances: Ms. Sanft, Ms. Casky, Mr. Aguilera 416-597-4110 representing Plaintiff Ms. Hitchman, Mr. Mahmood 416-865-8259 representing Defendant Minutes of Hearing entered in Vol. 866 page(s) 495 - 496 Abstract of Hearing placed on file

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 15-AUG-2012 directing that a CMC has been scheduled for 23-AUG-2012 starting at 1:00PM placed on file on 15-AUG-2012

Letter from Plaintiff dated 10-AUG-2012 requesting a CMC with Prothonotary Aalto to discuss dates for a DRC received on 10-AUG-2012

Letter from Apotex Inc. dated 13-AUG-2012 providing update on scheduling orders of the court. received on 13-AUG-2012

Letter from GSK dated 01-AUG-2012 advising of dates of meetings to discuss unanswered questions received on 01-AUG-2012

Memorandum to file from C. Doré, Ottawa dated 09-JUL-2012 A copy of the Notice of Appeal was sent to the Case Management Judge. (Aronovitch,P.) placed on file.

Copy of Notice of Appeal (Appeal Court File No. A-293-12 ) appealing the Order of the Honourable Mr. Justice O'Keefe dated June 11, 2012. filed in the Court of Appeal on 21-JUN-2012 on behalf of Appellant placed on file on 06-JUL-2012

Communication to the Court from the Registry dated 26-JUN-2012 re: letters from parties dated June 21 and June 22, 2012.

Letter from Defendants (Carol Hitchman) dated 22-JUN-2012 also writing on behalf of Plaintiff Pharmascience Inc. in file T-643-10 responding to GSK letter sent to Court June 21, 2012. We concur with the submissions made by Apotex that it is unnecessary to redact the subject matter of items 2, 11 and 29 on page 9 of the Draft Confidential Reasons of Justice O'Keefe rendered on June 11, 2012. received on 22-JUN-2012

Communication to the Court from the Registry dated 22-JUN-2012 re: Letter received June 21, 2012

Letter from Plaintiff (GSK) dated 21-JUN-2012 Pursuant to Paragaph 31 of Mr. Justice O'Keefe's decision dated June 11, 2012, the parties were given 10 days to request deletion of any material from the decision that they believe is confidential. GSK submits that the questions excerpted at paragraph 15 of the decision contain information that is confidential to GSK. In particular, Item #'s 2, 11, and 29 contain references to GSK's confidential scientific work. Accordingly, GSK respectfully requests that the text on Item #s 2, 11, and 29 be deleted or redacted in the public version of the reasons. received on 21-JUN-2012

Communication to the Court from the Registry dated 13-JUN-2012 re: GSK's status report

Letter from GSK dated 08-JUN-2012 providing status report per Order of 25-May-2012 received on 08-JUN-2012

Confidential Draft Reasons for Order and Order dated 11-JUN-2012. Result: Granted "These reasons are confidential to counsel and counsel shall have ten days to request deletion of any material they believe is confidential. If no submissions are received within ten days of counsel's receipt of this order, the confidential version of the reasons will become the public version of the reasons for order." placed on file on 11-JUN-2012

Letter from Plaintiff dated 30-MAY-2012 requesting a case management conference with Prothonotary Aalto to discuss the conducting of a mediation in this matter. received on 30-MAY-2012

Copy of Order dated 25-MAY-2012 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-14-09

Draft Order on consent concerning CMC held 15-May-2012 (sent to the CMJ electronically on 18-May-2012) consented to by all parties received on 18-MAY-2012

Ottawa 15-MAY-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the proposed amalgamated timetable submitted 17-Apr-2012 Result of Hearing: See abstract in T-14-09 held in chambers by way of Conference Call Duration per day: 15-MAY-2012 from 03:00 to 03:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 25min Appearances: Jordana Sanft, Jane Casky and Keith Aguilera 416-216-4798 representing GSK Carol Hitchman and Arif Mahmood 416-865-8259 representing PMS Comments: See comment in T-14-09 Minutes of Hearing entered in Vol. 862 page(s) 232 - 233 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 15-MAY-2012 re: in preparation for the CMC scheduled 15-May-2012

Communication to the Court from the Registry dated 18-APR-2012 re: the draft order rec'd 17-Apr-2012 re: CMC of 10-Apr-2012

Draft Order concerning CMC held on 10-APr-2012 consented to by all parties received on 17-APR-2012

Ottawa 10-APR-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the CMJ will leave it up to the parties to communicate with Aalto P. and request a teleconference to discuss scheduling the mediation and the subject of the mediation. The CMJ asked GSK to prepare a consolidated timetable which includes all remaining timelines in all three files held in chambers by way of Conference Call Duration per day: 10-APR-2012 from 10:00 to 11:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Jordana Sanft and Keith Aguilera 416-216-4000 representing GSK Carol Hitchman and Arif Mahmood 416-865-6600 representing PMS Minutes of Hearing entered in Vol. 860 page(s) 246 - 247 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 05-APR-2012 re: in preparation for the CMC scheduled 10-Apr-2012

Letter from counsel for PMS on behalf of all parties dated 05-APR-2012 in preparation for the CMC scheduled 10-Apr-2012 and addressing the Court's concerns as stated in the direction dated 28-Mar-2012 received on 05-APR-2012

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 27-Mar-2012 placed on file on 28-MAR-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 27-MAR-2012 directing that a case management teleconference will take place on April 10, 2012 at 10:00 placed on file on 27-MAR-2012 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 19-MAR-2012 directing that the case management teleconference scheduled to take place today at 4:00 p.m. is adjourned to a date to be determined. The parties are to provide their availability by the end of the day tomorrow for a case management teleconference in the two weeks following placed on file on 19-MAR-2012 Confirmed in writing to the party(ies)

Letter from Plaintiff dated 16-MAR-2012 requesting to reschedule the CMC scheduled for March 19th @ 4:00pm. received on 16-MAR-2012

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated March 5, 2012. placed on file on 06-MAR-2012

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 05-MAR-2012 directing that a case management teleconference is scheduled on March 19, 2012 at 4:00 pm to discuss the mediation placed on file on 05-MAR-2012 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 20-FEB-2012 re: the parties letters re: status of discussions re: mediation

Letter from PMS dated 17-FEB-2012 providing status re: mediation received on 17-FEB-2012

Letter from GSK dated 17-FEB-2012 providing status of the parties' discussions re: mediation and advising that the parties where unable to agree of the scope of the mediation received on 17-FEB-2012

Copy of Amended Order dated 02-FEB-2012 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-643-10

Covering letter from Defendant dated 31-JAN-2012 concerning Doc. Nos. 107 108 placed on file on 01-FEB-2012

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of the Amended Statement of Defence and Counterclaim upon Plaintiff by personal service on 27-JAN-2012 filed on 01-FEB-2012

Amended Defence and Counterclaim with consent of all parties filed pursuant to the Order of the Court dated 20-DEC-2011 filed on 01-FEB-2012

Copy of Order dated 31-JAN-2012 rendered by Roza Aronovitch, Prothonotary placed on file. Original filed on Court File No. T-643-10

Solicitor's certificate of service on behalf of c. KEITH AGUILERA confirming service of DOC 104 AND 105 upon Defendant by personal service on 27-JAN-2012 filed on 27-JAN-2012

Amended Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 27-JAN-2012

Further Amended Statement of Claim filed on 27-JAN-2012

Communication to the Court from the Registry dated 27-JAN-2012 re: Draft Order received on 27-JAN-2012 following CMC 18-JAN-2012

Letter from Defendant dated 27-JAN-2012 attaching a Draft Order for the proposed timetable estbalished at the CMC 18-JAN-2012 received on 27-JAN-2012

Ottawa 18-JAN-2012 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Counsel for PMS in T-2101-09 is to submit a draft order by 27-Jan-2011 held in chambers by way of Conference Call Duration per day: 18-JAN-2012 from 03:05 to 04:05 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Jordana Sanft and Keith Aguilera 416-216-4798 representing plaintiffs Arif Mahmood 416-865-2965 representing defendants Comments: With respect to the mediation and venue of such, the parties will jointly advise the Court of their preference in that regard no later than 30 days from today. Re PTC: For T-2101-09 and T-643-10 request for PTC shall be served and filed by mid December. The requirement to provide expert reports is waived. In T-14-09 request for PTC June 30, 2013. There is a disagrement as to date for delivery of expert reports in chief but other dates re: expert reports will be as proposed in proposed timetable Request for trial management conference to be made 90 days before trial at which time remainder of items re: trial will be discussed with trial judge. The Court tentatively sets down the week of October 29th, 2012 for hearing of motions re: 2nd round of discoveries. Another CMC will be scheduled on May 15, 2012 at 2:00 p.m. to see if they want to keep those dates. April 25 or 26 has been set aside for cross-examinations of Dominion Pharmacal. Service of affidavit of documents re: Dominion by February 10, 2012 as agreed between counsel for Glaxo and PMS in T-643-10 Minutes of Hearing entered in Vol. 855 page(s) 474 - 479 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 17-JAN-2012 re: in preparation for the CMC scheduled on 18-Jan-2012

Letter from Glaxo dated 16-JAN-2012 providing a proposed timetable on consent in preparation for the CMC scheduled on 18-Jan-2012 received on 16-JAN-2012

Acknowledgment of Receipt received from All parties with respect to Doc. #103 (Order from Aronovitch, P. dated January 11, 2012). placed on file on 11-JAN-2012

Order dated 11-JAN-2012 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Defendant dated 06-JAN-2012 Result: 1. The defendants, Zymcan Pharmaceuticals Inc. and Pharmel Inc. each will be bound by the final determination of the validity of the '083 Patent and its claims; and, in the event the '083 Patent and its claims are found to be valid the above named defendants each consent on application by the plaintiffs to judgment in the terms sought in paragraphs 1(a) and (c) of the Amended Statement of Claim. 2. This proceeding is otherwise stayed as against the Zymcan Pharmaceuticals Inc. and Pharmel Inc. pending the earliest of: (i) a motion by any one or more of the parties to lift the stay; (ii) a judgment in this action; 3. There are no costs of this motion. Filed on 11-JAN-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1145 page(s) 272 - 273 Interlocutory Decision

Transcript of hearing held at Toronto on 12-DEC-2011 received on 29-DEC-2011 Sent directly to presiding Judge 94 pages (including covering pages).

Letter from Defendant dated 06-JAN-2012 enclosing a draft Order to stay this proceeding as against Zymcan Pharmaceuticals Inc. and Pharmel Inc., on a without costs basis and consent of all parties for the same. Forwarded to CMJ and CMT-Ottawa. received on 06-JAN-2012

Communication to the Court from the Registry dated 28-DEC-2011 re: counsel for the plaintiff's in T-643-10 letter dated 23-Dec-2011

Letter from counsel for the plaintiff in T-643-10 dated 23-DEC-2011 providing status per Order of 2-May-2011 received on 28-DEC-2011

Letter from Defendants dated 21-DEC-2011 advising the Court of the dates scheduled for discoveries received on 21-DEC-2011

Acknowledgment of Receipt received from All parties with respect to Doc. #102 (Order from Aronovitch, P. dated December 20, 2011). placed on file on 21-DEC-2011

Order dated 20-DEC-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: THIS COURT ORDERS that a timetable be set for these proceedings as follows: 1. Counsel for the defendants in T-2101-09 is to write to the Court and to advise of all dates scheduled for second round examinations for discovery by December 21, 2011. 2. Any amendments to pleadings, including responsive pleadings, shall be made by January 27, 2012. 3. Updated affidavits of documents flowing from pleading amendments, if any, and affidavits of documents from new parties added to the actions, are to be served by February 3, 2012. 4. Second round examinations for discovery are to be completed by April 30, 2012. 5. Answers to undertakings or questions refused, if any, flowing from second round examinations for discovery are to be exchanged by June 29, 2012. 6. The parties shall exchange lists of questions flowing from second round examinations for discovery which have not been responded to by August 1, 2012. 7. The parties are to meet for one full day in person per motion to discuss the questions described in paragraph 6 above by August 24, 2012. 8. Motion records flowing from second round examinations for discovery are to be delivered by September 14, 2012. 9. Responding motion records flowing from second round examinations for discovery are to be delivered by October 5, 2012. 10. Answers to questions ordered answered flowing from second round examinations for discovery are to be exchanged within thirty five (35) days following the disposition of the motion. 11. There will be a further CMC on January 18, 2012 at 3:00 p.m. for 1.5 hours by teleconference to discuss: (a) Date and venue for a mediation, including the mediator and form of same. (b) Dates for adjudication of refusals motions arising from second round examinations for discovery (anticipated to be in October 2012). (c) A timetable, if necessary, for discovery, both documentary and oral, in respect of Dominion Pharmacal. (d) Dates for the remainder of the schedule. 12. For the purpose of the CMC on January 18, 2012, the parties shall submit a timetable on consent by no later than January 16, 2012, noting any disagreements thereupon. 13. The plaintiff in each proceeding shall requisition a trial management conference no later than sixty (60) days prior to the trial date. 14. A copy of this Order shall be placed on Court File T-14-09 and T-643-10. Filed on 21-DEC-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1144 page(s) 335 - 338 Interlocutory Decision

Communication to the Court from the Registry dated 19-DEC-2011 re: sending the draft proposed timetable to the CMJ by e-mail

E-mail from Apotex attaching a draft proposed scheduled on consent further to the CMC held on 14-Dec-2011 received on 19-DEC-2011

Ottawa 14-DEC-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the timetable going forward Result of Hearing: A partial timetable was established. A draft order re: timetable will be provided by end of day 19-Dec-2011. A further CMC by TC was scheduled on 18-Jan-2011 to continue the discussion about timetable, discuss dates and venue for a judicially assisted mediation, scheduling of refusals motion arising out the 2nd round of discoveries and discuss the issues raised in the confidential correspondence submitted December 13 and 14, 2011 held by way of video conference Senior Usher: R. Héroux Duration per day: 14-DEC-2011 from 02:10 to 03:30 Courtroom : Videoconference Room - 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 1h10min Appearances: Jordana Sanft and Keith Aguilera 416-216-4000 representing plaintiffs Carol Hitchman and Arif Mahmood 416-865-8259 representing Defendants Minutes of Hearing entered in Vol. 854 page(s) 302 - 303 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 13-DEC-2011 re: in preparation for the CMC scheduled 14-Dec-2011

Toronto 12-DEC-2011 BEFORE The Honourable Mr. Justice O'Keefe Language: E Before the Court: Motion Doc. No. 89 on behalf of Defendants/Plaintiffs by Counterclaim Result of Hearing: Matter reserved held in Court Senior Usher: Joe Mischuk Duration per day: 12-DEC-2011 from 09:38 to 11:33 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil Total Duration: 1h 57min Appearances: Carol Hitchman/Arif Mahmood 416-865-8259 representing Defendants/Plaintiffs by Counterclaim (Pharmascience) Lindsay Hill/David Scrimger 416-979-2211 representing Apotex (Plaintiff in T-14-09) Keith Aguilera/Jordana Sanft 416-216-3930 representing Plaintiffs/Defendants by Counterclaim (Glaxosmithkline) Court Reporter: Calypso Schincariol (ASAP Reporting Services Inc.) 416-861-8720 12-DEC-2011 Transcript requested Minutes of Hearing entered in Vol. 854 page(s) 266 - 272 Abstract of Hearing placed on file

Sealed envelope pursuant to the protective order of 29-Jun-2011 on behalf of Plaintiffs purporting to contain a letter in response to PMS's confidential letter dated 13-Dec-2011 Received on 14-DEC-2011

Sealed envelope pursuant to Protective Order dated 29-Jun-2011 on behalf of Defendants purporting to contain a letter in response to GSK's confidential letter dated 13-Dec-2011 Received on 13-DEC-2011

Joint Book of Authorities consisting of 4 volume(s) on behalf of all parties received on 09-DEC-2011

Sealed envelope pursuant to the protective order dated 29-Jun-2011 on behalf of Plaintiffs purporting to contain a letter in preparation for the CMC scheduled 14-Dec-2011 Received on 13-DEC-2011

Letter from Plaintiff dated 13-DEC-2011 providing their proposed timetable received on 13-DEC-2011

Letter from PMS (e-mail) dated 13-DEC-2011 providing a proposed timetable for this file and T-643-10 and advising that the parties have not been able to reach an agreement on the timetable received on 13-DEC-2011

Letter from Jean-Charles René (Norton Rose Canada LLP) dated 05-DEC-2011 re: name and address change. received on 05-DEC-2011

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of doc 100 and Joint Book of Authorities upon Defendant by process server on 09-DEC-2011 filed on 09-DEC-2011

Joint Book of Authorities consisting of 4 volume(s) on behalf of Plaintiff received on 09-DEC-2011 Sent directly to Presiding Judge

Sealed envelope pursuant to the Court Order dated Sept 29, 2010 as amended on Jan 12, 2011 and June 29, on behalf of Plaintiff purporting to contain Responding Motion Record of GSK Filed on 09-DEC-2011

Letter from Defendant dated 09-DEC-2011 Enclosed documents for hearing:Joint book of authorities and Responding Motion Record received on 09-DEC-2011

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of doc 98, Joint Book of Relevant Documents upon Plaintiffs/Responding Parties by personal service on 30-NOV-2011 filed on 07-DEC-2011

Sealed envelope pursuant to Protective Order dated 7-DEC-2009 on behalf of Defendants/Moving Parties purporting to contain Joint Book of Relevant Documents (2 Volumes) Received on 07-DEC-2011

Sealed envelope pursuant to Protective Order dated 7-DEC-2009 on behalf of Defendants/Moving Parties purporting to contain Motion Record containing the following original document (s): 97 Number of copies recieved: 3 on behalf of the Defendants/Moving Parties Filed on 07-DEC-2011

Written Representations contained within a Motion Record on behalf of Defendants/Moving Parties concerning Motion Doc. No. 89 filed on 07-DEC-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 01-DEC-2011 directing that The case management conference by teleconference scheduled for December 14, 2011 will now be heard by videoconference. If the parties indicate that the timetable will be on consent then the case management conference will be heard by teleconference. placed on file on 01-DEC-2011

Ottawa 01-DEC-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss extension of timelines for second round discovery Result of Hearing: The timelines are to be fixed and placed in the new timetable which will be discussed at the case conference on December 14, 2011 held by way of Conference Call Duration per day: 01-DEC-2011 from 10:00 to 10:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 35min Appearances: Ms Sanft and Mr. Aigulera 416-216-4798 representing Plaintiff Mr. Tan 416-777-2647 representing Defendant Ms Hitchman and Mr. MaMood 416-865-8259 representing Defendant MS MCNicoll 514-340-7845 representing Client representative of Pharmascience Ms Hebert 1-800-363-7988 representing Client representative of Laboratoire Riva Ms Emond 450-646-9611 representing Client representative of Pro-Doc Comments: This matter was heard in conjunction with T-14-09 and T-643-10. For full minutes see the Minutes in T-14-09. The Court Directed that the case management conference scheduled for December 14, 2011 would proceed at 2:00 by videoconference in lieu of a teleconference, but if the parties write to the Court that there is a timetable on consent the case management conference will then be heard by teleconference. Mr. Tan is to provide fixed dates for himself and his clients for discovery to Ms Sanft by December 6, 2011. These timelines are to be placed in the timetable submitted on December 13, 2011. The Court indicated that the timelines in the timetable will be fixed for the date that the Trial is presently scheduled for. Parties are also to have a provision in the timetable for samples motions. Minutes of Hearing entered in Vol. 853 page(s) 397 - 398 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 30-NOV-2011 re: Preparation of the file for the CMC on December 1, 2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 30-NOV-2011 directing that There will be a case management conference, by teleconference on December 1, 2011, commencing at 10:00 for thirty minutes. placed on file on 30-NOV-2011 Confirmed in writing to the party(ies)

Letter from Pharmascience Inc dated 25-NOV-2011 providing dates of availability for a case conference received on 25-NOV-2011

Letter from Pharmascience dated 25-NOV-2011 providing dates of availability for a case conference received on 25-NOV-2011

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated November 22, 2011. placed on file on 23-NOV-2011

Letter from GSK dated 24-NOV-2011 providing its availability for a CMC the week of November 28, 2011 received on 24-NOV-2011

Communication to the Court from the Registry dated 24-NOV-2011 re: GSK's letter dated 23-Nov-2011 (sent electronically to the CMJ)

Letter from GSK dated 23-NOV-2011 advising of the status of the motions to amend pleadings received on 23-NOV-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 22-NOV-2011 directing that "By November 25, 2011 parties are to provide their availability to attend a case conference during the week of November 28, 2011 to discuss an extension of the timelines for the conclusion of the second round of discoveries. In the interim parties are to try to fix the dates for the completion of as much of the discoveries as possible by the end of February 2012." placed on file on 23-NOV-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 22-NOV-2011 re: sending the parties' correspondence re: moving up trial dates if dates become available to the Judicial Administrator and the CMJ as well as the correspondence re: issues with scheduling discoveries to the CMJ

Letter from PMS in T-643-10 dated 18-NOV-2011 explaining why they are not available in January and February 2012 for discoveries and asking that the timeline for the completion of the 2nd round of discoveries be changed to 30-Apr-2012 received on 18-NOV-2011

Letter from GSK dated 18-NOV-2011 advising of dates scheduled for second round of discoveries and advising of issues about scheduling discoveries with PMS and requesting direction of the Court received on 18-NOV-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 16-Nov-2011 placed on file on 16-NOV-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 16-NOV-2011 directing that "Glaxo is to advise as to the status of the motion to amend filed on July 15, 2011 (doc. 33 in T-14-09 and doc. 55 in T-2101-09) by no later than November 23, 2011." placed on file on 16-NOV-2011 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from All parties with respect to Docs. #94-95-96 (Orders from Aronovitch, P. dated November 14, 2011). placed on file on 15-NOV-2011

Order dated 14-NOV-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Special Case Result: Partially granted (With regards to motion document #63 in T-643-10). Filed on 14-NOV-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1141 page(s) 100 - 110 Interlocutory Decision

Order dated 14-NOV-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 86 Result: Questions ordered answered 1. Riva shall answer the questions represented by Serial Nos. 29, 33, and 35. Questions agreed upon between GSK and Riva at the hearing of the motion Questions agreed to be answered by Riva 2. Riva agrees to provide an answer to the question represented by Serial No. 62. Questions agreed to be withdrawn by GSK 3. GSK agrees to withdraw the questions represented by Serial Nos. 39, 40, and 45 on the basis that Riva will produce (1) total sales revenues (company wide or by division, depending on how costs are captured), (2) valacyclovir sales revenues, (3) costs incurred by the company or division (depending on how they are captured), and (4) costs or P&L's specific to valacyclovir. 4. GSK agrees to withdraw the question represented by Serial No. 64. 5. Riva shall supply written answers to the questions it undertook to answer or that it has been ordered to answer on or before November 30, 2011. 6. There will be no costs of the motion. Filed on 14-NOV-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1141 page(s) 88 - 92 Interlocutory Decision

Order dated 14-NOV-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 85 Result: Questions ordered answered 1. Pro Doc shall answer the questions represented by Serial Nos. 35, 37, 42, 45, 46, and 47. Questions agreed upon between GSK and Pro Doc at the hearing of the motion Questions agreed to be withdrawn by GSK 2. GSK agrees to withdraw the questions represented by Serial Nos. 39, 43, and 44 on the basis that the Court ordered that Pro Doc shall answer the question represented by Serial No. 37. 3. Pro Doc shall supply written answers to the questions it undertook to answer or that it has been ordered to answer on or before November 30, 2011. 4. There will be no costs of the motion. Filed on 14-NOV-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1141 page(s) 84 - 87 Interlocutory Decision

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated November 14, 2011. placed on file on 14-NOV-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 14-NOV-2011 directing that "Re: Correspondence of November 10, 2011 from Mr. Kierans Pharmascience will have until no later than November 18, 2011 to respond. The correspondence and response, if any, will thereafter be provided to the office of the Judicial Administrator." placed on file on 14-NOV-2011 Confirmed in writing to the party(ies)

Letter from Defendants dated 15-NOV-2011 in response to the direction of the Court dated 14-Nov-2011 and in response to GSK's letter dated 10-Nov-2011 received on 15-NOV-2011

Communication to the Court from the Registry dated 10-NOV-2011 re: GSK's letter dated 10-Nov-2011

Letter from GSK dated 10-NOV-2011 requesting that if dates prior to September 2013 become available, the Court seek to set down the hearing at such earlier date. received on 10-NOV-2011

Acknowledgment of Receipt received from All parties with respect to Doc. #93 (Order from Aronovitch, P. dated November 4, 2011). placed on file on 04-NOV-2011

Order (time and place) dated 04-NOV-2011 rendered by Roza Aronovitch, Prothonotary fixing Trial of the matter to be heard at Special Sitting in Toronto on 09-SEP-2013 to begin at 09:30 duration: 40d language: E Filed on 04-NOV-2011 cc's sent to parties entered in J. & O. Book, volume 1140 page(s) 107 - 108 Transmittal letters placed on file

Communication to the Court from the Registry dated 01-NOV-2011 re: the status report dated 28-Oct-2011 and the draft orders rec'd 28-Oct-2011

Draft Order concerning Motion Doc. No. 85 received on 28-OCT-2011

Draft Order concerning Motion Doc. No. 86 received on 28-OCT-2011

Letter from Plaintiff dated 28-OCT-2011 providing a status report received on 28-OCT-2011

Ottawa 27-OCT-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss new trial dates in 2013 Result of Hearing: the Court advised the parties that the trial dates were changed to September 9, 2013 and that the Order scheduling the trial will be issued by the week of November 7, 2011 held in chambers by way of Conference Call Duration per day: 27-OCT-2011 from 02:00 to 02:10 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 10min Appearances: Ms. Jordana Sanft 416-216-4000 representing GSK Ms. Carol Hitchman 416-865-8259 representing PMS Minutes of Hearing entered in Vol. 851 page(s) 454 - 455 Abstract of Hearing placed on file

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-OCT-2011 directing that granted the parties' request for an extension of the timeline set by paragraph 1k of the May 2, 2011 Order until November 30, 2011 placed on file on 26-OCT-2011

Acknowledgment of Receipt received from all parties with respect to the directions of the Court dated 21-Oct-2011 and 26-Oct-2011 (2 directions) placed on file on 26-OCT-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 21-OCT-2011 directing that The parties' request for an extension of time to submit the draft orders pertaining to the motions to compel heard October 13 and 14, 2011 is granted until October 28, 2011 as requested placed on file on 21-OCT-2011 Confirmed in writing to the party(ies)

Letter from Plaintiff - GlaxoSmithKline Inc. dated 26-OCT-2011 Re: consent of all parties to additional time to 30-NOV-2011 to exchange answers to questions ordered to be answered from the refusals motion by 31-OCT-2011. cc to all parties received on 26-OCT-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-OCT-2011 directing that a case management teleconference will take place on October 27, 2011 at 10:00 a.m. for 30 min to discuss new trial dates for the trial in 2013 placed on file on 26-OCT-2011 Confirmed in writing to the party(ies)

Letter from counsel for PMS in T-643-10 on behalf of all counsel in these matters dated 21-OCT-2011 requesting an extension of time until October 28, 2011 to provide draft orders re: motions to compel heard on October 13 and 14, 2011 (sent in pdf to the CMJ on 21-Oct-2011) received on 21-OCT-2011

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated October 14, 2011. placed on file on 19-OCT-2011

Toronto 14-OCT-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: court will schedule a PTC Dec 14, 2011. Parties are to submit a timetable dec 13, 2011 to cmt-ott- email. held in Court Senior Usher: Sybil Mirosolin Duration per day: 14-OCT-2011 from 10:00 to 11:50 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Jacqueline Smith Total Duration: 1h 50min Appearances: Ms. Jane Caskey 416-216-4000 representing Plaintiff Ms. Jordanna Sanft 416-216-4000 representing Plaintiff Mr. Christopher Tan 416-777-0888 representing Defendant Ms. Carol Hitchman 416-777-0888 representing Defendant Mr. Jerry Topolski 416-979-2211 representing Defendant Mr. David Scrimger 416-979-2211 representing Defendant Minutes of Hearing entered in Vol. 851 page(s) 225 - 226 Abstract of Hearing placed on file

Letter from counsel for defendants dated 17-OCT-2011 advising that they currently anticipate that some evidence of Riva will be in French received on 17-OCT-2011

Letter from GSK dated 13-OCT-2011 advising that the parties have agreed that mediation before trial is appropriate and that it may be incorporated into a scheduling order but that the parties have not yet agreed on the timing of the mediation ie before or after expert reports and asking that the timing, identity of the mediator and material for mediation be determined at the CMC in December received on 13-OCT-2011

Letter from GSK dated 12-OCT-2011 making submissions re: length of trial received on 13-OCT-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 14-OCT-2011 directing that a case management teleconference will take place on December 14, 2011 at 2:00 p.m. to discuss the timetable going forward. The parties are to file, jointly or separately, a proposed timetable by noon on December 13th, 2011 at the cmt e-mail address placed on file on 14-OCT-2011 Confirmed in writing to the party(ies)

Toronto 13-OCT-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 57 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Sybil Mirosolin Duration per day: 13-OCT-2011 from 02:30 to 04:00 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Jacqueline Smith Total Duration: 1h 30min Appearances: Ms. Jane Caskey 416-216-4000 representing Plaintiff Mr. Keith Aguilera 416-216-4000 representing Plaintiff Mr. Christopher Tan 416-777-0888 representing Defendant Mr. Ken Crofoot 416-979-211 representing Defendant Minutes of Hearing entered in Vol. 851 page(s) 72 - 73 Abstract of Hearing placed on file

Toronto 21-SEP-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 57 on behalf of Defendant Result of Hearing: Matter reserved Before the Court: Motion Doc. No. 87 on behalf of Plaintiff Result of Hearing: Matter reserved Before the Court: Motion Doc. No. 88 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Sybil Mirosolin Duration per day: 21-SEP-2011 from 09:30 to 05:15 Courtroom : Courtroom No. 4-D - Toronto Court Registrar: Jacqueline Smith Total Duration: 3d Appearances: Ms. Jane Caskey 416-216-4000 representing Plaintiff Mr.Ketih Aguilera 416-216-4000 representing Plaintiff Mr. Christopher Tan 416-777-0888 representing Defendant Ms. Jenene Roberts 416-979-2211 representing Defendant Ms Jordanna Sanft 416-216-4000 representing Plaintiff Ms Carol Hitchman 416-777-0888 representing Defendant Minutes of Hearing entered in Vol. 851 page(s) 57 - 71 Abstract of Hearing placed on file

Letter from defendants dated 12-OCT-2011 providing submissions on length of trial per Order of the Court dated 28-Sep-2011 received on 12-OCT-2011

Sealed envelope pursuant to protective order dated 29-Jun-2011 on behalf of GSK Received on 11-OCT-2011

Sealed envelope pursuant to protective order dated 29-Jun-2011 on behalf of GSK purporting to contain amended chart re: motion to compel doc. 61 Received on 11-OCT-2011

Letter from GSK dated 11-OCT-2011 attaching a confidential amended chart for the hearing of motions 61 and 62 received on 11-OCT-2011

Order dated 07-OCT-2011 rendered by Roza Aronovitch, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 87 Result: granted in part (see order for details) Filed on 07-OCT-2011 Transmittal Letters placed on file. entered in J. & O. Book, volume 1136 page(s) 456 - 462 Interlocutory Decision

Order dated 07-OCT-2011 rendered by Roza Aronovitch, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 57 Result: granted in part (see order for details) The Court's decision is with regard to Motion Doc. No. 88 Result: granted in part (see order for details) Filed on 07-OCT-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1136 page(s) 447 - 455 Interlocutory Decision

Correction to General Sitting concerning Motion Doc. No. 89 Hearing added to General Sitting at Toronto on 12-DEC-2011 at 09:30 duration: 2h Language: E Reason for correction: parties agreed matter could be heard at general sittings on this day

Letter from Defendant dated 06-OCT-2011 confirming that motion doc. 89 should be returnable for general sittings in Toronto on 12-DEC-2011 at 9:30am received on 06-OCT-2011

E-mail from GSK attaching a draft order re: motion 54 (motion record doc 60) sent electronically to the CMJ on 6-Oct-2011 received on 05-OCT-2011

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of Doc. no. 89 upon Plaintiff by telecopier on 05-OCT-2011 filed on 05-OCT-2011

Notice of Motion on behalf of Defendant returnable (but no hearing date indicated at this time) for to appeal on order of Prothonotary Aronovitch from motion heard between 23-SEP-2011 and 26-SEP-2011 with respect to questions in Schedule "C" to be set aside filed on 05-OCT-2011

Notice of motion in sealed envelope on behalf of Plaintiff returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compell the defendants to answer questions for examinations filed on 15-JUL-2011

SEALED NOTICE OF MOTION on behalf of Plaintiff returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compel (re: Debbie Ship) filed on 15-JUL-2011

SEALED NOTICE OF MOTION on behalf of Plaintiff returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compel (re: Andre St.Denis) filed on 15-JUL-2011

SEALED NOTICE OF MOTION on behalf of Plaintiff returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to compel (re: Marcel Raymond) filed on 15-JUL-2011

E-mail from counsel for the defendant attaching a draft order on consent re: motions docs 50 and 57 (motion record doc 64). (Sent electronically to the CMJ on October 5, 2011) received on 05-OCT-2011

Acknowledgment of Receipt received from All parties with respect to Doc. #84 (Order from Aronovitch, P. dated September 28, 2011). placed on file on 29-SEP-2011

Order dated 28-SEP-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: 1. Case management conference to fix trial dates a) A case management conference is scheduled to take place in person, in Toronto on October 14, 2011, following the continuation of the motions to compel being heard in Court File Nos. T-2101-09, T-643-10 and T-14-09. The purpose of the case management conference is to formally fix trial dates in Court File Nos. T-2101-09, T-643-10, and T-14-09. b) For that purpose, the parties shall make submissions in writing regarding the length of the trial in T-2101-09, T-643-10, as consolidated for hearing, by no later than October 12, 2011, and in the event they do not consent, or consent to a trial of more than forty (40) days, shall serve and file Trial Charts by the same date. c) The parties in T-14-09, are to similarly serve and file submissions and/or Trial Charts in respect of a trial of twenty five (25) days, by October 12, 2011. 2. Continuation of motions to compel a) The continuation of the following motions to compel shall be heard, in this order, in Toronto on October 13 and 14, 2011: i) Apotex and Pharmascience et al.'s motion to compel GSK (Document #51). ii) GSK's motion to compel Riva (Document #61). iii) GSK's motion to compel Pro Doc (Document #62). iv) GSK's motion to compel Pharmascience (Document #48). b) In respect of Document #61 and Document #62, motions which have not yet commenced, the responding parties shall serve and file revised 5 column Charts containing only those items remaining for the Court¿s adjudication by noon on October 11, 2011, at cmt_ottawa@cas-satj.gc.ca. c) In respect of Document #51 and Document #48, motions which have already commenced, the responding parties shall, based on the existing 5 column Charts, advise the Court of those items remaining for adjudication by noon on October 11, 2011. 3. Draft orders for completed motions are to be filed at cmt_ottawa@cas-satj.gc.ca, as follows: for Documents #64 and 37, by October 4, 2011; for Document #60 by October 5, 2011. 4. A copy of this Order shall be placed on Court File T-14-09 and T-643-10. Filed on 28-SEP-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1135 page(s) 353 - 355 Interlocutory Decision

E-mail on behalf of counsel for GSK attaching a amended draft order pursuant to the request of the Court during the September 26, 2011 hearing placed on file on 27-SEP-2011

E-mail received from GSK further to the Court's request at the hearing of September 23, 2011 attaching a draft direction to schedule a CMC on 14-Oct- 2011 following the continuation of the hearing of the motions to compel. Forwarded to the CMJ by e-mail placed on file on 26-SEP-2011

Letter from Plaintiffs dated 19-SEP-2011 advising that its preference is that the trial in Court File No. T-643-10 be heard starting April 8, 2013 together with the trial in Court File No. T-2101-09. (Transmitted to the CMJ by e-mail) received on 19-SEP-2011

Solicitor's certificate of service on behalf of C. Tan confirming service of doc. 78-79-80 upon Plaintiffs by personal service on 13-SEP-2011 filed on 13-SEP-2011

Solicitor's certificate of service on behalf of Keith Aguilera confirming service of doc 70 to 75 upon Defendants by process server on 13-SEP-2011 filed on 13-SEP-2011

Letter from Plaintiffs dated 12-SEP-2011 describing in detail what documents they are filing with regards to the motions to compel scheduled to heard starting September 21, 2011 received on 13-SEP-2011

Solicitor's certificate of service on behalf of Keith Aguilera confirming service of doc 77 upon Plaintiffs in T-14-09 and T-2101-09 and Defendants in T-643-10 by process server on 13-SEP-2011 filed on 13-SEP-2011

Letter from Plaintiffs dated 13-SEP-2011 suggesting the order in which the motions to compel should be heard received on 13-SEP-2011

Covering letter from Plaintiffs dated 12-SEP-2011 concerning explaining the documents filed for the motions to compel to be heard in Toronto starting on 21-Sep-2011 placed on file on 13-SEP-2011

Responding motion record of Pharmascience Inc. re: Plaintiffs' motion to compel answers to questions arising out of the examination for discovery of Debby Ship filed on 13-SEP-2011

Responding motion record of Laboratoire Riva Inc. re: Plaintiff's motion to compel answers to questions arising out of the Examination for discovery of André St-Denis filed on 13-SEP-2011

Responding motion record of Pro Doc Limitée re: Plaintiffs' motion to compel answers to questions arising out of the examination for discovery of Marcel Raymond filed on 13-SEP-2011

GSK's Book of Authorities for GSK's Responding Motion Record as well as GSK motion to compel in T-14-09 (MR doc. 37), PMS' MR doc 60, Riva's MR doc. 61, Pro Doc's MR doc 62 in T-2101-09 and PMS's MR doc 48 in T-643-10. Only one set filed per direction of the Court given at the CMC on 8-Sep-2011 received on 13-SEP-2011

Book of Authorities of GSK (2 volumes)to accompany doc 77. Filed in this file only per instructions of the Court given at the CMC on 8-Sep-2011 received on 13-SEP-2011

GSK's responding motion record with respect to Apotex's motion doc 30 in T-14-09 and PMS' motions 50 and 57 in T-2101-09 (motion record 64 in T-2101- 09) Only one copy was filed per instructions of the Court given at the CMC on 8-Sep-2011 filed on 13-SEP-2011

GSK's Joint Brief of Relevant Documents re: Apotex' motion to compel in T-14-09 doc 30 and PMS' motions to compel docs. 50 and 57 all of which motion record doc 64 pertains to. Only one copy for both files were filed per direction of the Court given at the CMC held on September 8, 2011 filed on 13-SEP-2011

Transcript of the examination for discovery of Marcel A. Raymond, a representative of Pro Doc Limitée, held on February 1, 2011 to accompany the material filed for motion 52 and motion record 62 filed by GSK filed on 13-SEP-2011

Brief of relevant documents for motion to compel Pro Doc Limitée filed to accompany motion 52 and motion record 64 filed on 13-SEP-2011

Transcript of the examination for discovery of André St-Denis, a representative of Laboratoire Riva Inc. held on March 3, 2011 filed to accompany the material filed in support of motion 53 motions record 61 filed on 13-SEP-2011

Brief of relevant documents for motion to compel Laboratoire Riva Inc. filed to accompany the material filed in support of motion 53 and motion record 61 filed by GSK filed on 13-SEP-2011

Transcript of the examination for discovery of Debbie Ship, a representative of Pharmascience Inc. to accompany the material filed in support of motion doc.54 motion record doc 60 filed on 13-SEP-2011

Brief of relevant documents for motion to Compel Pharmascience Inc. to accompany material filed re: motion 54 and motion record doc. 60 filed by GSK filed on 13-SEP-2011

Covering letter from Apotex dated 12-SEP-2011 concerning doc 43,44,45 filed in T-14-09 only but re: motions filed in this file and file T-643-10 and T-14-09 placed on file on 13-SEP-2011

Ottawa 13-SEP-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the scheduling of the trial Result of Hearing: GSK is to provide a proposed schedule leading to mediation of certain aspect of these matters. GSK will advise if his client is agreable to proceeding with PMS's Section 8 in 2013 and Apotex's in 2014. if not both will proceed in 2014. GSK is to advise by 19-Sep-2011. Depending on what is decided, the duration of the trials will have to be adjusted and a further CMC will be scheduled to discuss the change of the durations held in chambers by way of Conference Call Duration per day: 13-SEP-2011 from 11:10 to 11:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Patrick Kierans, Jordana Sanft and Jane Caskey 416-216-4000 representing Plaintiff Carol Hitchman and Arif Mahmood 416-865-8259 416-865-8259 representing Defendants Minutes of Hearing entered in Vol. 849 page(s) 133 - 134 Abstract of Hearing placed on file

Ottawa 08-SEP-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss hearing of motions to compel scheduled 21-27 Sept Result of Hearing: The responding parties are to serve and file their responding motion records by noon on September 13th (which shall include an "aide-mémoire" containing pertinent documents and exhibits and a 5 column chart as described)accompanied by a covering letter explaining the content of the material. The Court consolidated the motion material and allowed the parties to file only one set of three copies of the responding material to be placed on one of the files. The parties are to advise as to the Order in which the motions to compel will be heard by September 12, 2011.The motions to amend in this file and in T-14-09 are to be made returnable on a general sitting on which Madam Prothonotary Aronovitch is sitting. held in chambers by way of Conference Call Duration per day: 08-SEP-2011 from 01:05 to 02:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h10min Appearances: Jordana Sanft and Jane Caskey 416-216-4798 representing Plaintiffs Carol Hitchman 416-865-8259 representing Defendants Comments: The responding motion records are to be filed in Ottawa by noon 13-Sep-2011 Minutes of Hearing entered in Vol. 848 page(s) 472 - 473 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 07-SEP-2011 re: Glaxo's motion to amend to be scheduled

Covering letter from Plaintiffs dated 02-SEP-2011 concerning Doc. No. 69 placed on file on 02-SEP-2011

Written Submissions on behalf of plaintiffs concerning in preparation for the CMC scheduled 13-Sep-2011 to discuss joint trial filed on 02-SEP-2011

****** CANCELLED ****** Solicitor's certificate of service on behalf of CHRISTOPHER TAN confirming service of Motion Record of Pharmascience Inc. upon Plaintiff by e-mail on 31-AUG-2011 filed on 01-SEP-2011

****** CANCELLED ****** Sealed envelope pursuant to Confidentiality Order dated 12-JAN-2011 on behalf of Pharmascience Inc. purporting to contain Moving Party Motion Record Filed on 01-SEP-2011

****** CANCELLED ****** Notice of Motion contained within a Motion Record on behalf of Pharmascience Inc. returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order compelling the representatives of the Responding Parties to re-attend for examination for discovery 0 filed on 01-SEP-2011

Solicitor's certificate of service on behalf of Arif Mahmood confirming service of Doc 64 and a Book of Authority upon Plaintiff by personal service on 31-AUG-2011 filed on 31-AUG-2011

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 31-AUG-2011

Sealed envelope pursuant to pursuant to the court order dated 07-DEC-2009. on behalf of Defendant purporting to contain the motion to compel answers to undertakings. Filed on 31-AUG-2011

Solicitor's certificate of service on behalf of Jane E. Caskey confirming service of doc. 60, 61, and 62 upon Defendant by process server on 31-AUG-2011 filed on 31-AUG-2011

Sealed envelope pursuant to order dated 29-jun-2011 on behalf of Plaintiff purporting to contain Motion Record to Compel-discovery of M.R. Filed on 31-AUG-2011

Sealed envelope pursuant to order dated 29-jun-2011 on behalf of Plaintiff purporting to contain Motion Record to Compel- discovery of A.SD Filed on 31-AUG-2011

Sealed envelope pursuant to protective order dated 29-jun-2011 on behalf of Plaintiff purporting to contain Motion Record to compel - discovery D.S Filed on 31-AUG-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 19-AUG-2011 directing that the moving parties' motion record re: motions to compel are to be served and filed by 31-Aug-2011 and the responding motion records are to be serve and filed in Ottawa, directly to the attention of Julie Dulac, by noon on 9-Sep-2011 placed on file on 19-AUG-2011 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 18-AUG-2011 directing that the moving parties' motion record re: motions to compel shall be served and filed by August 31, 2011 and the responding parties' motion records by September 16, 2011 placed on file on 18-AUG-2011 Confirmed in writing to the party(ies)

Letter from plaintiff in T-643-10 dated 17-AUG-2011 requesting an extension of time to file the moving parties' motion record and the responding motion records re: motions to compel received on 17-AUG-2011

Acknowledgment of Receipt received from all parties with respect to the Court's direction dated 10-Aug-2011 placed on file on 10-AUG-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 10-AUG-2011 directing that the case management teleconference scheduled to take place on September 13 2011 at 2:00 p.m. will now take place at 11:00 a.m. placed on file on 10-AUG-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 10-AUG-2011 re: Apotex's status report dated 29-Jul-2011

Covering letter from Defendants dated 05-AUG-2011 concerning Doc. No. 59 placed on file on 05-AUG-2011

Written Submissions on behalf of defendants concerning implications of having two trials and in prep. for the CMC of 13-Sep-2011 filed on 05-AUG-2011

Letter from Apotex dated 29-JUL-2011 providing a quarterly status report and advising that they are meeting the timelines received on 29-JUL-2011

Letter from Defendant dated 19-JUL-2011 the notice of motion filed 15-jul-2011 was indavertently filed withoutà a sealed evelope pursuant to order dated 29-Septemebr 2010. Attached are envelopes for notice of motion to be placed in seal. received on 20-JUL-2011

Solicitor's certificate of service on behalf of Carol Hitchman confirming service of doc 57 upon Plaintiff by Courier on 15-JUL-2011 filed on 15-JUL-2011

Sealed envelope puportating to contain a notice of motion on behalf of Defendant returnable 21-september 2011 for a motion to compel. filed on 15-JUL-2011

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of doc 52-55 upon Defendant by process server on 15-JUL-2011 filed on 15-JUL-2011

Notice of Motion on behalf of Plaintiff returnable at Special Sitting in Toronto on 21-SEP-2011 to begin at 09:30 for an Order to add parties and amend the pleadings filed on 15-JUL-2011

****** CANCELLED ****** Sealed envelope pursuant to Order of the Court on behalf of Plaintiff purporting to contain Notice of Motion (to compel re: DEBBIE SHIP) returnable in Toronto on September 21-23, 26/27, 2011 Filed on 15-JUL-2011

****** CANCELLED ****** Sealed envelope pursuant to Order of the Court on behalf of Plaintiff purporting to contain Notice of Motion (to compel re: ANDRÉ ST-DENIS) returnable in Toronto on Sept 21-23, 26/27, 2011 Filed on 15-JUL-2011

****** CANCELLED ****** Sealed envelope pursuant to Order of the Court on behalf of Plaintiff purporting to contain Notice of Motion (to compel answers re: MARCEL RAYMOND) returnable Sept. 21-23, 26/27, 2011 Filed on 15-JUL-2011

Solicitor's certificate of service on behalf of Christopher Tan confirming service of doc 50 upon Plaintiff by personal service on 15-JUL-2011 filed on 15-JUL-2011

Sealed envelope pursuant to Order dated 12-Jan-2011 on behalf of Defendant purporting to contain Notice of motion pursuant to order dated 02-may-2011 Filed on 15-JUL-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 23-Jun-2011 placed on file on 24-JUN-2011

Communication to the Court from the Registry dated 30-JUN-2011 re: forwarding the amended protective and confidentiality order issues by Mr. Justice Campbell (Appeal of decision of 12-Jan-2011) to the CMJ for her information

Acknowledgment of Service received from Defendant ***re-faxed as original transmission was incomplete with respect to Doc. 49 placed on file on 30-JUN-2011

Letter from Defendant dated 29-JUN-2011 re draft order Doc 49 received on 29-JUN-2011

Acknowledgment of Service received from the parties with respect to Doc 49 placed on file on 29-JUN-2011

Further Amended Protective Order & Confidentiality Order Pursuant to Rule151 dated 29-JUN-2011 rendered by The Honourable Mr. Justice Campbell Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 38 Result: granted per the order of Jan 12-11 Filed on 29-JUN-2011 certified copies sent to parties entered in J. & O. Book, volume 1128 page(s) 83 - 92 Interlocutory Decision

Consent on behalf of Defendant to Doc 38 draft order filed on 29-JUN-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 23-JUN-2011 directing that the hearing of June 23, 2011 is adjourned to September 13, 2011 at 2:00 p.m. for 1.5 hours. Apotex's supplementary submissions are to be served and filed by July 22, 2011. Pharmascience's submissions are to be served and filed by August 5, 2011 and GSK's submissions by September 2, 2011 filed on 24-JUN-2011 Confirmed in writing to the party(ies)

Ottawa 23-JUN-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss issues re: trial as identified in the recent correspondence Result of Hearing: Direction to follow held in chambers by way of Conference Call Duration per day: 23-JUN-2011 from 03:05 to 04:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h10min Appearances: Patrick Kierans, Jordana Sanft and Jane Caskey 416-597-5907 representing plaintiffs Carol Hitchman and Arif Mahmood 416-865-8259 representing defendants Minutes of Hearing entered in Vol. 846 page(s) 257 - 258 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 22-Jun-2011 placed on file on 23-JUN-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 22-JUN-2011 directing that a case management teleconference is scheduled on June 23, 2011 at 3:00 p.m. placed on file on 22-JUN-2011 Confirmed in writing to the party(ies)

Toronto 21-JUN-2011 BEFORE The Honourable Mr. Justice Campbell Language: E Before the Court: Motion Doc. No. 38 on behalf of Defendant Result of Hearing: Motion withdrawn on consent of counsel agreeing to a proposed Draft Order held in Court Senior Usher: Ron Cooksey Duration per day: 21-JUN-2011 from 09:30 to 11:50 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Jeff Weir Total Duration: 2h20min Appearances: Jane Caskey, Keith Aguilera (416) 216-1899 representing Plaintiff Christopher Tan, Carol Hitchman (416) 777-2647 representing Defendant Court Reporter: Calypso Schincarial, ASAP Reporting Services (416) 861-8720 21-JUN-2011 Transcript not requested Comments: Heard in conjunction with File T-643-10. For details of minutes taken, please see File T-643-10. Minutes of Hearing entered in Vol. 846 page(s) 124 - 125 Abstract of Hearing placed on file

Memorandum to file from Julie Dulac dated 21-JUN-2011 the Court asked me to contact the parties to attempt to schedule a CMC by TC to discuss the parties' latest correspondence placed on file.

Toronto 20-JUN-2011 BEFORE The Honourable Mr. Justice Campbell Language: E Before the Court: Continuation of the Meeting re Motion to be heard on June 21-11 Doc 38 Result of Hearing: to be heard on June 21-11 held in Court Duration per day: 20-JUN-2011 from 12:00 to 12:40 Courtroom : Judge's Chambers - Toronto Court Registrar: Jeff Weir Total Duration: 40 min Appearances: Jane Caskey, Keith Aguilera (416) 216-3904 representing Plaintiff Christopher Tan, Carol Hitchman (416) 777-2647 representing Defendant Comments: Heard in conjunction with File T-643-10. For details of minutes taken, please see File T-643-10. Minutes of Hearing entered in Vol. 846 page(s) 86 - 87 Abstract of Hearing placed on file

Toronto 13-JUN-2011 BEFORE The Honourable Mr. Justice Campbell Language: E Before the Court: Meeting Meeting to discuss the progress and to see if a resolution can be found in regard to the Motion to be heard on June 21-11. Doc 38 Result of Hearing: Matter adjourned to Special Sitting in Toronto on 20-JUN-2011 to begin at 12:00 by teleconference call held by way of Conference Call in chambers Duration per day: 13-JUN-2011 from 03:00 to 03:50 Courtroom : Judge's Chambers - Toronto Court Registrar: Jeff Weir Total Duration: 50min Appearances: Patrick Kierans, Keith Aguilera (416) 216-3904 representing Plaintiff Christopher Tan, Carol Hitchman (416) 777-2647 representing Defendant Comments: Heard in conjunction with file T-643-10. For details of minutes taken, please see File T-643-10 Minutes of Hearing entered in Vol. 845 page(s) 409 - 410 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 14-JUN-2011 re: verbal communication bringing Glaxo's letter dated 13-Jun-2011 to the case management prothonotary's attention

Letter from GlaxoSmithKline Inc. dated 13-JUN-2011 "...We are in receipt of letters from counsel...dated dJune 3, 2011. ...GSK should not be denied its right to have its patent adjudicated upon at the earliest possible opportunity..." cc to Defendants received on 13-JUN-2011

Oral directions received from the Court: The Honourable Mr. Justice Campbell dated 13-JUN-2011 directing that a teleconference call be scheduled at 3pm today (June 13-11) in regard to motion Doc 38 placed on file on 13-JUN-2011

Letter from Glaxo dated 08-JUN-2011 further to the instructions of Madam Prothonotary Aronovitch at the CMC on May 24, 2011 confirming that all parties agree that the current schedule in respect of these actions set by Order dated May 2, 2011 does not need to be amended and will continue to govern the next steps of these actions received on 08-JUN-2011

Letter from Defendant to Federal Court dated 03-JUN-2011 responding to Mr. Kierens letter dated 1-JUN-2011 received on 03-JUN-2011

Letter from Plaintiff dated 01-JUN-2011 regarding name change of counsel of record from Ogilvy Renault LLP to Norton rose OR LLP, and the letter from Ms. Hitchman, dated 26-May-2011. received on 01-JUN-2011

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of Doc 45 upon Defendants by process server on 27-MAY-2011 filed on 27-MAY-2011

Motion Record in response to Motion Doc. No. 38 containing the following original document(s): 44 Number of copies received: 3 on behalf of the Plaintiff (2 vols. - same material as T-643-10) filed on 27-MAY-2011

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 38 filed on 27-MAY-2011

Communication to the Court from the Registry dated 27-MAY-2011 re: PMS's letter dated 26-May-2011

Letter from PMS dated 26-MAY-2011 providing submissions as to why 25 to 30 days for the trial in this file and in T-643-10 is not sufficient. received on 27-MAY-2011

Acknowledgment of Receipt received from both parties with respect to the direction of the Court dated 26-May-2011 placed on file on 27-MAY-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 26-MAY-2011 directing that following the case conference of May 24, 2011, trial dates have been tentatively set aside as follows: T-2101-09 and T-643-10 - 25-30 days, in English, starting April 8, 2013, at 9:30 a.m. in Toronto. T-14-09- 25-30 day in English, starting January 13, 2014 at 9:30 a.m. in Toronto. Same judge as above placed on file on 26-MAY-2011 Confirmed in writing to the party(ies)

Ottawa 24-MAY-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to follow held in chambers by way of Conference Call Duration per day: 24-MAY-2011 from 04:00 to 05:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Patrick Kierans, Jordana Sanft and Jane Caskey 416-216-4000 representing Plaintiffs Carol Hitchman and Arif Mahmood 416-865-6600 representing Defendants Comments: See comments in T-14-09 Minutes of Hearing entered in Vol. 844 page(s) 293 - 294 Abstract of Hearing placed on file

Letter from Defendant dated 13-MAY-2011 Requesting that the following material be present at the hearing of the motion on June 2nd (see letter for details) received on 13-MAY-2011

Solicitor's certificate of service on behalf of Christopher Tan confirming service of doc 42 upon Plaintiff by personal service on 13-MAY-2011 filed on 13-MAY-2011

Motion Record containing the following original document(s): 38 41 Number of copies received: 3 on behalf of Defendant filed on 13-MAY-2011

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 38 filed on 13-MAY-2011

Letter from GSK dated 10-MAY-2011 in response to PMS's letter dated May 9, 2011 received on 10-MAY-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 13-May-2011 placed on file on 13-MAY-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 13-MAY-2011 directing that "A case management teleconference is scheduled to take place on May 24, 2011 at 4:00 p.m." placed on file on 13-MAY-2011 Confirmed in writing to the party(ies)

****** CANCELLED ****** Letter from Pharmascience dated 11-MAY-2011 providing availability for CMC received on 11-MAY-2011

Letter from Glaxo dated 12-MAY-2011 providing availability for CMC received on 12-MAY-2011

Letter from Counsel for Pharmascience - Carol Hitchman dated 11-MAY-2011 "Further to the direction of Prothonotary Tabib of today's date, counsel for Pharmascience is available on the following dates to attend a case management teleconference..." cc all parties received on 11-MAY-2011

Acknowledgment of Receipt received from All parties with respect to the Oral Direction of Aronovitch, P. dated May 11, 2011. placed on file on 11-MAY-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 11-MAY-2011 directing that "By close of business on May 12, 2011 parties are to provide their availability for the weeks of May 16, 23 and 30, 2011 to attend a case management teleconference to discuss the scheduling of the trial." placed on file on 11-MAY-2011 Confirmed in writing to the party(ies)

Letter from Defendant dated 09-MAY-2011 in response to Mr Kieran's letter dated May 4, 2011. received on 09-MAY-2011

Acknowledgment of Receipt received from Defendant with respect to Memorandum of the Chief Justice dated April 20, 2011. placed on file on 20-APR-2011

Acknowledgment of Receipt received from Plaintiff with respect to Memorandum from the Chief Justice dated April 20, 2011. placed on file on 20-APR-2011

****** CANCELLED ****** Letter from Apotex dated 06-MAY-2011 in response to Glaxo's letter dated 4-May-2011 received on 09-MAY-2011

Communication to the Court from the Registry dated 06-MAY-2011 re: sending Glaxo's letter date 4-May-2011 to the CMJ and the Jud. Adm.

Letter from Glaxo dated 04-MAY-2011 regarding proposed trial dates received on 04-MAY-2011

Acknowledgment of Receipt received from All parties with respect to Doc. #40 (Order from Aronovitch, P. dated May 2, 2011). placed on file on 03-MAY-2011

Order dated 02-MAY-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from "GSK" dated 08-APR-2011 Result: 1. A timetable be set for this proceeding as follows: (a) The parties shall provide the Court with a quarterly status report, the first of which to be prepared by GlaxoSmithKline Inc. by April 29, 2011. (b) The parties shall exchange answers to undertakings and questions taken under advisement and/or refused from the first round discovery by June 15, 2011. (c) The parties shall serve and file a Notice of Motion together with a schedule setting out a list of all disputed questions by July 15, 2011. (d) The parties shall meet in mid-July - mid-August 2011 to discuss the disputed questions and to narrow the questions in dispute. (e) The GlaxoSmithKline Inc. parties shall move to amend its pleadings by writing to the Court seeking an order on consent or by serving and filing a Notice of Motion to amend its pleading by July 15, 2011. (f) The parties shall provide the Court with a quarterly update report to be prepared by Apotex Inc. by July 29, 2011. (g) The motion records for the moving parties for the motions on disputed questions shall be served and filed by August 22, 2011. (h) The motion records for the responding parties for the motions on disputed questions shall be served and filed by September 7, 2011. (i) The refusal motions arising out of the first round of discovery will be heard for 4-5 days in Toronto, on September 21-23, 2011 and on September 26 and 27, 2011, if necessary. (j) The parties shall provide the Court with a quarterly update report to be prepared by Pharmascience Inc. in T-2101-09 by October 29, 2011. (k) The parties shall exchange answers to questions ordered to be answered by October 31, 2011. (l) The parties shall write to the Court by November 18, 2011 providing dates for second round discoveries of all parties' representatives, which shall be completed by January 31, 2012. (m) The parties shall write to the court by November 18, 2011 to request a case conference to be scheduled during the first 2 weeks of December 2011, to discuss the remaining pre-trial steps in these actions and set a timetable up to trial. (n) The parties shall provide the Court with a quarterly update report to be prepared by Pharmascience Inc. in T-643-10 by December 30, 2011. Filed on 02-MAY-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1122 page(s) 310 - 312 Interlocutory Decision

Communication to the Court from the Registry dated 02-MAY-2011 re: the letter dated 28-Apr-2011 sent electronically to the Court

Letter from GlaxoSmithKline Inc. et al dated 28-APR-2011 We represent GlaxoSmithKline Inc. et al., and are writing on bhalf of all parties to these proceedings. We ask that this letter be brought to the attention of Madam Prothonotary Aronovitch, the case Management Judge. pursuant to the case management conference held on March 29, 2011 and draft scheduling orders filed on April 8, 2011, we are writing to provide the quarterly status report for the period ending April 29, 2011. We confirm that the first round of examinations for discovery was completed on April 4, 2011 for all parties. The parties are currently working on preparing answers to undertakings to meet the june 15, 2011 deadline as provided in the draft scheduling orders. received on 28-APR-2011

Memorandum to file from Chief Justice dated 20-APR-2011 "The Chief Justice has indicated the following: The Defendants' motion (Document #38) appealing the order of Madam Prothonotary Aronovitch dated January 12, 2011 will be heard before this Court at 180 Queen Street West, in the City of Toronto, Ontario, on Tuesday the 21st day of June, 2011 at 9:30 in the forenoon for a duration of four (4) hours. The Defendants' motion record is to be served and filed no later than May 13, 2011. The Plaintiffs' responding motion record is to be served and filed no later than May 27, 2011. placed on file.

Communication to the Court from the Registry dated 13-APR-2011 re: Apotex's letter dated 12-Apr-2011

****** CANCELLED ****** Letter from Apotex dated 12-APR-2011 in response to GSK's letter dated 8-Apr-2011 and attaching minutes of the CMC which took place on 29-Mar-2011 received on 12-APR-2011

Communication to the Court from the Registry dated 11-APR-2011 re: the minutes of the CMC held 19-Mar-2011 and draft order re: timetable

Letter from Glaxo dated 08-APR-2011 re: minutes of the CMC held on 29-Mar-2011 and the draft order re: timetable received on 08-APR-2011

Draft Order concerning CMC held on 29-Mar-2011 received on 08-APR-2011

Minutes of the case management conference held on 29-Mar-2011 received on 08-APR-2011

Ottawa 29-MAR-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss schedule to trial Result of Hearing: Counsel for Glaxo is to provide minutes of the CMC approved as to form and content and a draft scheduling order on consent held by way of video conference in Court Senior Usher: S. Patry Duration per day: 29-MAR-2011 from 02:10 to 04:15 Courtroom : Videoconference Room - 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac 29-MAR-2011 from 02:10 to 04:15 Courtroom : Videoconference Room - Toronto Court Registrar: Yoginder Gulia Total Duration: 2h Appearances: Jordana Sanft and Jane Caskey 416-216-4000 representing Plaintiffs Carol Hitchman and Arif Mahmood 416-865-6600 representing Defendants Draft Decision to be submitted by Plaintiffs Comments: The Court advised that she would ask for the trial to be scheduled for a duration of 50 days in March or April 2013. Glaxo advised that the pleadings might have to be amended. Such motion or draft on consent by 15-Jul-2011. Motions to compel re: 1st round by same date. 4 days are set aside ( (September 20 to 23 and continuing September 26 if needed) for hearing of motions to compel. Production by 31-Oct-2011. By 18-Nov-2011 parties will advise of scheduled for 2nd round of discoveries. The Court originally said that a CMC to discuss the rest of the schedule would be scheduled in the first 2 weeks of December but has since advised that she would like the CMC to take place earlier in the fall. End of 2nd round of disc, by end of January 2012. The timetable will provide for status reports to be provided quaterly alternating between parties starting with Glaxo on 29-Apr-2011 The Court asked for the minutes and the draft order on consent by 8-Apr-2011 Minutes of Hearing entered in Vol. 841 page(s) 51 - 60 Abstract of Hearing placed on file

Letter from Pharmascience dated 29-MAR-2011 proving the Court with their availability for the hearing of the motion Doc. #38 received on 29-MAR-2011

Communication to the Court from the Registry dated 24-MAR-2011 re: the parties' submissions dated March 21 and 22, 2011 re: assessment of length of trial etc in preparation for the CMC scheduled 29-Mar-2011

Letter from Pharmascience Inc. (Sprigings on behalf of Gardiner Roberts) dated 22-MAR-2011 providing submissions re: assessment of length of trial and timetable to trial for the CMC scheduled to take place on 29-Mar-2011 received on 22-MAR-2011

Letter from Glaxo dated 21-MAR-2011 providing submissions on assessment of length of trial, statement of issues etc.. for the CMC scheduled on 29-Mar-2011 received on 21-MAR-2011

Communication to the Court from the Registry dated 23-MAR-2011 re: Notice of Motion (Doc.#38)

Letter from Plaintiff(GlaxoSmithKline) dated 11-MAR-2011 Counsel's availabilities for the scheduling of a motion, pursuant to the Notice of Motion of Pharmascience Inc. et al. filed on January 24, 2011. received on 11-MAR-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 7-Mar-2011 placed on file on 07-MAR-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 07-MAR-2011 directing that the case management conference originally scheduled to take place by video conference on March 29, 2011 at 10:00 a.m. is now rescheduled to take place by video conference on March 29, 2011 at 2:00 p.m. for 2.5 hours placed on file on 07-MAR-2011 Confirmed in writing to the party(ies)

Letter from Glaxo dated 01-MAR-2011 further to the 15-Nov-2010 Order and the 9-Feb-2011 direction confirming dates of availability for a CMC to discuss timetables and trial dates received on 01-MAR-2011

Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 18-Feb-2011 placed on file on 21-FEB-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 18-FEB-2011 directing that a case conference to fix a timetable for the remainder of the proceeding and assess the length of trial for the three actions will take place, by videoconference, on March 29, 2011 for 2.5 hours commencing at 10:00 a.m. By March 22, 2011, parties are to file their assessment of the length of the trial of their own proceeding, as pleaded, by way of a statement of the issues for trial, and the evidence to be adduced in respect of the issues on which they bear the burden. In addition, parties will serve and file detailed timetables up to an including the exchange of rebuttal expert evidence placed on file on 18-FEB-2011 Confirmed in writing to the party(ies)

Letter from Applicant dated 18-FEB-2011 requesting an interpreter for consecutive interpretation from French to English for an examination for dicovery that will take place on March 3,2011 starting at 9:00 am and ending at 5:00 pm at the offices of Laboratoire Riva inc. located at 660 boul. Industriel, Blainville, Québec, J7C 3V4 received on 21-FEB-2011

Communication to the Court from the Registry dated 17-FEB-2011 re: the parties' availability for an in person CMC in Toronto

E-mail on behalf of Glaxo advising of their availability for an in person CMC on April 14, 2011 received on 17-FEB-2011

E-mail from counsel for Glaxo advising of their availability for a CMC in person in Toronto received on 11-FEB-2011

E-mail from counsel for the defendants advising of their availability for a CMC received on 10-FEB-2011

Acknowledgment of Receipt received from all parties with respect to direction dated 09-Feb-2011 placed on file on 11-FEB-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 09-FEB-2011 directing that parties are to provide their availability to attend a 2 hour case conference in Toronto during the weeks of March 28 or Aopril 14, 2011, to finalize timetables with the object of securing trial dates for the trial of the actions together or consecutively by the same judge placed on file on 09-FEB-2011 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from Mr. Kierans & Ms. Hitchman with respect to the Written Direction of Aronovitch, P. dated Feb/07/2011. placed on file on 07-FEB-2011

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 07-FEB-2011 directing that 1. The examination for discovery of GlaxoSmithKline Inc. et al.'s (collectively, "GSK") corporate representative, Dr. Tom Krenitsky, shall be held on January 25-27, 2011. 2. The examination for discovery of GSK's corporate representative, Ms. Cindy Roll, shall be held on February 8-9, 2011. 3. The examination for discovery of GSK's corporate representative, Mr. Norm Vojir, shall be held on March 9-10, 2011 and, only if required, March 11, 2011. 4. The examination for discovery of Pharmascience Inc.'s representative shall be held on February 28, March 1 and 8, 2011 (March 8, 2011, only if required). 5. The examination for discovery of Pro Doc Limitée's corporate representative shall be held on February 1, 2011. 6. The examination for discovery of Laboratoire Riva Inc.'s corporate representative shall be held on March 3, 2011. placed on file on 07-FEB-2011 Confirmed in writing to the party(ies)

Ottawa 07-FEB-2011 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: amended direction will be issued held in chambers by way of Conference Call Duration per day: 07-FEB-2011 from 10:00 to 10:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: Warren Sprigings and Christopher Tan 416-777-0888 representing Pharmascience Inc. in T-643-10 Carol Hitchman 416-865-8259 representing Defendants Patrick Kierans and Jordana Sanft 416-216-3904 representing Plaintiffs Comments: The Court agrees that no amendment should be made to the confidentiality order until the appeal is dealt with. The Court will issue a direction requesting the parties' availability in this file and in T-643-10 and T-14-09 for an in person CMC to discuss the scheduling of the trial during the weeks of March 28 or April 4, 2011 Minutes of Hearing entered in Vol. 837 page(s) 253 - 256 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties with respect to direction dated 2-Feb-2011 placed on file on 03-FEB-2011

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 02-FEB-2011 directing that a case management teleconference will take place on February 7, 2011 at 10:00 a.m. for 1 hour placed on file on 02-FEB-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 02-FEB-2011 re: the correspondence of the parties dated 26-Jan-2011 and 31-Jan-2011

Letter from Mr. Tan on Behalf of Ms. Hitchman dated 26-JAN-2011 requesting that the direction scheduling the examinations for discoveries be amended (par 4 of December 9, 2010 direction) received on 01-FEB-2011

Letter from Glaxo dated 31-JAN-2011 in response to Pharmascience Inc's letter dated 26-Jan-2011 in T-643-10 received on 31-JAN-2011

Communication to the Court from the Registry dated 26-JAN-2011 re: letter from the defendants dated January 25, 2011

Letter from Defendant dated 25-JAN-2011 "We wish to advise the court that the parties have agreed that it will not be necessary to examine for discovery certain of the defendants, namely Dominion Pharmacal, Zyman Pharmaceuticals Inc. and Pharmel Inc. Accordingly, the direction dated December 9, 2010, which requires discovery of these defendants, should be amended to remove the names. We expect to be filing a formal consent and order as to a stay of the action against these defendants in the near future." received on 25-JAN-2011

Communication to the Court from the Registry dated 25-JAN-2011 re: letters from the parties dated January 17, 19 and 20, 2011

Letter from Pharmascience dated 20-JAN-2011 in reply to GlaxoSmithKine's letter dated January 19, 2011 received on 20-JAN-2011

Letter from GlaxoSmithKline Inc. dated 19-JAN-2011 in response to the letter from Pharmascience dated January 17, 2011 received on 19-JAN-2011

Memorandum to file from S.Aciro dated 24-JAN-2011 Notice of Motion (Doc.38) communicated to Prothonotary Aronovitch placed on file.

Solicitor's certificate of service on behalf of CHRISTOPHER TAN confirming service of DOC.38 upon Plaintiffs (Defendants by Counterclaim) by telecopier on 24-JAN-2011 filed on 24-JAN-2011

Notice of Motion on behalf of Defendants (Counsel Carol Hitchman 416-865-8259) returnable (but no hearing date indicated at this time) for an appeal of the decision of Roza Aronovitch, Prothonotary dated 24-JAN-2011 Doc. No. 35 filed on 24-JAN-2011

Letter from Pharmascience Inc dated 17-JAN-2011 submissions regarding the confidentiality Order and the protective orders received on 17-JAN-2011

Acknowledgement of receipt from Mr. Tan and Mr. Aguilera of the Orders issued on January 12, 2011 placed on file on 13-JAN-2011

Affidavit of Bola Sholubi sworn on 15-DEC-2010 on behalf of Plaintiff in support of Motion Doc. No. 15 filed on 12-JAN-2011

Amended Protective Order and Confidentiality Order Pursuant to Rule 151 dated 12-JAN-2011 rendered by Roza Aronovitch, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Order dated 12-JAN-2011 Result: granted Filed on 12-JAN-2011 copies sent to parties entered in J. & O. Book, volume 1111 page(s) 18 - 27 Interlocutory Decision

Order dated 12-JAN-2011 rendered by Roza Aronovitch, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 15 Result: THIS COURT ORDERS that: 1. Affidavit of Bola Sholubi is accepted for filing. 2. The motion is granted. 3. Brief further submissions, if any, arising from the above Endorsement may be made in respect of this proceeding, as well as Court File T-643-10, by no later than January 17, 2011, and its response, if any, by January 19, 2011. 4. Costs shall be in the cause. Filed on 12-JAN-2011 copies sent to parties entered in J. & O. Book, volume 1111 page(s) 15 - 17 Interlocutory Decision

Acknowledgment of Receipt received from Mr. Aguilera & Ms. Hitchman with respect to Doc. #34 (Order from Aronovitch, P. dated Dec/23/2010). placed on file on 24-DEC-2010

Order dated 23-DEC-2010 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 20 Result: 1. The plaintiffs shall provide a further and better affidavit of documents in accordance with the above endorsement by no later than twenty (20) days prior to the date set for the examination for discovery of Mr. Norman Vojir. 2. The plaintiffs shall produce the deposition transcript of Ms. Lilia Beauchamp, inventor of Canadian Patent No. 1,340,083 ("the '083 Patent"), from a proceeding in the United States District Court for the District of New Jersey, Smithkline Beecham, et al v. Ranbaxy Laboratories, et al., Civil Action No.: 3:2003-cv-02158 (the "U.S. Case") involving the corresponding patent on valacyclovir on or before January 17, 2011. If the Protective Order in the U.S. Case legally prevents the Plaintiffs from disclosing the deposition transcript, the plaintiffs shall have the right to return to this Court to seek an appropriate amendment to this Order. The plaintiffs shall also have the obligation to seek an order from the U.S. Court having jurisdiction (the "U.S. Court") which relieves the plaintiffs from any obligations pursuant to the Protective Order in the U.S. Case in order to comply with this Order. The plaintiffs shall serve on counsel for the defendants the materials filed with the U.S. Court seeking relief from the Protective Order in the U.S. Case and will support any application brought by the defendants for standing as amicus curiae or intervener in the application to the U.S. Court. The production of Ms. Beauchamp's transcript is without prejudice to the defendant's right to examine her as the assignor of the '083 Patent pursuant to Federal Court Rule 237(4) on matters not addressed by her transcript in the U.S. proceeding, should her health permit such an examination. 3. As success is divided, costs of the motion fixed in the sum of $1,690 are payable to the defendants, in the cause. Filed on 23-DEC-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1109 page(s) 417 - 421 Interlocutory Decision

E-mail on behalf of Defendants attaching a draft order re their motion for a further and better affidavit of documents forwarded to the Court electronically placed on file on 20-DEC-2010

Toronto 16-DEC-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Motion Doc. No. 15 on behalf of Plaintiff Result of Hearing: Matter reserved Before the Court: Motion Doc. No. 20 on behalf of Defendant Result of Hearing: Matter reserved held in Court Senior Usher: Greg Nevin Duration per day: 16-DEC-2010 from 09:30 to 14:59 Courtroom : Courtroom No. 4-B - Toronto Court Registrar: John DiDomizio Total Duration: 5hr29min Appearances: Patrick Kierans / Keith Aguilera 416-216-4000 representing Plaintiff Warren Sprigings / Christopher Tan 416-777-0888 representing Defendant Carol Hitchman / Arif Mahmood 416-906-0790 representing Defendant Draft Decision to be submitted by Carol Hitchman Comments: The matter was heard together with file T-643-10. Minutes of Hearing entered in Vol. 835 page(s) 365 - 369 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 13-DEC-2010 re: the defendants' letter dated December 9, 2010

Letter from defendants dated 09-DEC-2010 attaching a proposed reply affidavit re: defendant's motion for a further and better affidavit of documents received on 09-DEC-2010

Acknowledgment of Receipt received from Ms. Sanft & Ms. Hitchman with respect to the Written Direction from Aronovitch, P. dated Dec/9/2010. placed on file on 10-DEC-2010

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 09-DEC-2010 directing that 1. The examination for discovery of GlaxoSmithKline Inc. et al.'s (collectively, "GSK") corporate representative, Dr. Tom Krenitsky, shall be held on January 25-27, 2011. 2. The examination for discovery of GSK's corporate representative, Ms. Cindy Roll, shall be held on February 8-9, 2011. 3. The examination for discovery of GSK's corporate representative, Mr. Norm Vojir, shall be held on March 9-10, 2011 and, only if required, March 11, 2011. 4. The examination for discovery of Pharmascience Inc., Dominion Pharmacal, Zymcan Pharmaceuticals Inc. and Pharmel Inc.'s representative shall be held on February 22, March 1 and 8, 2011. 5. The examination for discovery of Pro Doc Limitée¿s corporate representative shall be held on February 1, 2011. 6. The examination for discovery of Laboratoire Riva Inc.'s corporate representative shall be held on March 3, 2011. placed on file on 09-DEC-2010 Confirmed in writing to the party(ies)

****** REMOVED ****** Letter from Defendants dated 08-DEC-2010 Enclosing Toronto copy of Responding Motion Record filed in Ottawa on 7-DEC-2010 received on 08-DEC-2010

Covering letter from Defendants dated 06-DEC-2010 concerning Doc. No. 32 placed on file on 07-DEC-2010

Solicitor's certificate of service on behalf of Christopher Tan confirming service of 32 upon plaintiffs by personal service on 06-DEC-2010 filed on 07-DEC-2010

Motion Record in response to Motion Doc. No. 15 containing the following original document(s): 30 31 Number of copies received: 1 on behalf of defendants filed on 07-DEC-2010

Written Representations contained within a Motion Record on behalf of defendants concerning in response to motion doc 15 filed on 07-DEC-2010

Affidavit of Grace Chang sworn on 06-DEC-2010 contained within a Motion Record on behalf of defendants in opposition to Motion Doc. No. 15 with Exhibits A to H filed on 07-DEC-2010

Solicitor's certificate of service on behalf of C. Keith Aguilera confirming service of doc. 28 upon Defendant by personal service on 06-DEC-2010 filed on 07-DEC-2010

Motion Record in response to Motion Doc. No. 20 containing the following original document(s): 26 27 Number of copies received: 3 on behalf of Plaintiff (GSK et al)-2 VOLUMES filed on 07-DEC-2010

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 20 filed on 07-DEC-2010

Affidavit of Bola Sholubi sworn on 06-DEC-2010 contained within a Motion Record on behalf of Plaintiff (GSK et al.) with consent to extend the time for filing in opposition to Motion Doc. No. 20 with Exhibits A to I filed on 07-DEC-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 03-DEC-2010 directing that granting GSK's request dated 2-Dec-2010 placed on file on 03-DEC-2010 Confirmed in writing to the party(ies)

Letter from GSK dated 02-DEC-2010 on behalf of all parties requesting an extension of deadline to file their respective responding motion records in Ottawa by noon on December 7, 2010 received on 02-DEC-2010

Acknowledgment of Receipt received from both parties (receipt confirmed by the defendants by Ms. Howes, Ms. with respect to Hitchman's law clerk verbally) of Madam Prothonotary Aronovitch's direction dated November 29, 2010 placed on file on 01-DEC-2010

Communication to the Court from the Registry dated 01-DEC-2010 re: GSK's letter dated 30-Nov-2010

Letter from GSK dated 30-NOV-2010 attaching a draft direction setting out the dates the parties have agreed to for the first round of examinations for discovery received on 01-DEC-2010

Memorandum to file from Julie Dulac dated 30-NOV-2010 the parties have advised that e-mailing directions and decisions to them in this file is appropriate. For the plaintiff pkierans@ogilvyrenault.com, jsanft@ogilvyrenault.com, dbadurina@ogilvyrenault.com and kaguilera@ogilvy renault.com. For the defendants chitchman@gardiner-roberts.com and Ms. Hitchman's law clerk phowes@gardiner-roberts.com placed on file.

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 29-NOV-2010 directing that The plaintiff's (PMS) motion for a protective order filed November 15, 2010 (doc.11 in T-643-10), the defendant's (GSK) motion for a variance to paragraph 10 of the confidentiality and protective order (doc. 20 in T-643- 10) and the plaintiff's (GSK) motion for a variance to paragraph 10 of the confidentiality and protective order issued by the Court on September 29, 2010 (doc. 15 in T-2101-09) will be heard, in Toronto on December 16, 2010 starting at 9:30 a.m. Responding motion records are to be served and filed, in Ottawa, by noon on December 6, 2010 addressed directly to Julie Dulac. The respondent's (PMS et al's) motion for an order compelling the plaintiffs to provide a further and better affidavit of documents and an order compelling the production of representatives (doc 20 in T-2101-09) will be heard on December 16th only if the Court is of the view that there is sufficient time following the hearing of the above motions. The responding record is to be similarly served and filed, in Ottawa, by noon, on December 6, 2010. placed on file on 29-NOV-2010 Confirmed in writing to the party(ies)

Solicitor's certificate of service on behalf of CAROL HITCHMAN confirming service of DOC 25 upon Plaintiff by courier on 26-NOV-2010 filed on 26-NOV-2010

Motion Record containing the following original document(s): 20 21 22 23 Number of copies received: 3 on behalf of Defendant filed on 26-NOV-2010

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 20 filed on 26-NOV-2010

Affidavit of Behrouz Amouzgar sworn on 26-NOV-2010 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 20 filed on 26-NOV-2010

Affidavit of Sandy O'Donohue sworn on 25-NOV-2010 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 20 with Exhibits A-E filed on 26-NOV-2010

Notice of Motion contained within a Motion Record on behalf of Respondent returnable (but no hearing date indicated at this time) for an Order compelling the Plaintiffs to provide a further and better affidavit of documents, and order compelling the production of a representative from each of the Plaintiffs, compelling the Plaintiffs to make the intervenor available to be examined for discovery filed on 26-NOV-2010

Solicitor's certificate of service on behalf of C. KEITH AGUILERA confirming service of DOC 18 upon Defendant by process server on 26-NOV-2010 filed on 26-NOV-2010

Motion Record containing the following original document(s): 15 16 17 Number of copies received: 3 on behalf of Plaintiff filed on 26-NOV-2010

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 15 filed on 26-NOV-2010

Affidavit of BOLA SHOLUBI sworn on 25-NOV-2010 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 15 with Exhibits A-J filed on 26-NOV-2010

Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable (but no hearing date indicated at this time) for A VARIANCE TO PARAGRAPH 10 OF THE PROTECTIVE ORDER AND CONFIDENTIALITY ORDER ISSUED BY THE COURT ON 29-SEP-2010 filed on 26-NOV-2010

Communication to the Court from the Registry dated 26-NOV-2010 re: the parties' availability for the hearing of motions re: protective order and possibly the defendants' motion for production of a representative for discovery

Communication to the Court from the Registry dated 22-NOV-2010 re: the parties' availability for a hearing of motion re: protective order

E-mails from the parties advising of their availability for a hearing of motions re: protective orders in this file and T-643-10 placed on file on 25-NOV-2010

Acknowledgment of Receipt received from both parties with respect to the direction of the Court dated 24-Nov-2010 placed on file on 25-NOV-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 24-NOV-2010 directing that Re: correspondence dated November 22, 2010 form GSK " The motions will be set down at a special sitting of the Court. For that purpose, by November 26 2010, parties are to provide their availability to attend a special sitting of the Court during the week of December 13, 2010, on December 20 or 22, 2010. Once the special sitting is set down, the date for the delivery of responding records will be fixed to be filed by no later than 6 days prior to the date of hearing." placed on file on 24-NOV-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 23-NOV-2010 re: GSK's letter dated November 22, 2010

Letter from GSK dated 22-NOV-2010 seeking directions re: filing date for responding material re: proposed motion to vary conf. order received on 22-NOV-2010

Proof of Service of Fax received from Ms. Hitchman & Mr. Aguilera with respect to Doc. #14 (Order from Aronovitch, P. dated Nov/15/2010) placed on file on 16-NOV-2010

Order dated 15-NOV-2010 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The first round of examinations for discovery shall be completed by March 31, 2011. 2. Dates for the first round of examinations for discovery shall be fixed by November 30, 2010, and a draft direction setting out the dates shall be filed the same day for issuance by the Court. 3. By no later than November 26, 2010, the defendants shall serve and file a motion, if any, for the production of a discovery representative from each of the plaintiffs. 4. The parties are to adhere to paragraph 2, notwithstanding paragraph 3. 5. By no later than March 1, 2011, the plaintiffs shall request a case conference and provide the availability of counsel for all parties to attend same during the weeks of March 28 and April 4, 2011 to set a trial date for the within proceeding. Filed on 16-NOV-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1105 page(s) 298 - 299 Interlocutory Decision

Communication to the Court from the Registry dated 15-NOV-2010 re: draft Order re: CMC 8-Nov-2010

Draft Decision concerning CMC held 8-Nov-2010 (each party submitted their own version) received on 10-NOV-2010

Ottawa 08-NOV-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the schedule Result of Hearing: The plaintiffs to submit a draft order by noon on November 10, 2010 held in chambers by way of Conference Call Duration per day: 08-NOV-2010 from 02:10 to 02:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jordana Sanft 416-216-4000 representing Plaintiffs Carol Hitchman 416-865-8259 representing Defendants Minutes of Hearing entered in Vol. 833 page(s) 13 - 16 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 08-NOV-2010 re: the CMC schedule today at 2:00 p.m.

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 20-OCT-2010 directing that a case management telephone conference will take place on November 8, 2010 at 2:00 p.m. placed on file on 20-OCT-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 19-OCT-2010 re: availability of the parties for a CMC

Letter from defendants dated 18-OCT-2010 providing their availability for CMC received on 19-OCT-2010

Letter from Plaintiff dated 19-OCT-2010 providing their availability for a CMC received on 19-OCT-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 15-OCT-2010 directing that Re: Correspondence of October 8 and 12, 2010 form the plaintiffs and the defendants respectively "The correspondence raises issues that may be best addressed at a case conference. Accordingly, by no later than October 20, 2010, parties are to provide their availability to attend a case conference during the weeks of October 25 and November 8, 2010 to set a timetable to accelerate the prosecution of this action." placed on file on 15-OCT-2010 Confirmed in writing to the party(ies)

****** REMOVED ****** Copy of a Letter from Apotex, Plaintiff in T-14-09 dated 12-OCT-2010 in response to the Court's direction dated 29-Sep-2010 and GSK's submissions dated 08-Oct-2010 received on 12-OCT-2010

Communication to the Court from the Registry dated 13-OCT-2010 re: The submissions of GSK dated 08-Oct-2010 and the defendants' submissions dated 12-Oct-2010

Letter from defendants dated 12-OCT-2010 further to the direction of the Court dated 29-Sep-2010 and in response to GSK's submissions dated 8-Oct-2010 received on 12-OCT-2010

Letter from GSK dated 08-OCT-2010 providing a proposed timetable further to the direction of the Court dated 29-Sep-2010 received on 08-OCT-2010

Protective Order and Confidentiality Order Pursuant to Rule 151 dated 29-SEP-2010 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 07-SEP-2010 Result: "Please see Order for details." Filed on 29-SEP-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1101 page(s) 346 - 356 Interlocutory Decision

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 29-SEP-2010 directing that "The discussions with respect to consolidation if any, of these files is not meant to effect a stay of these proceedings. By October 8, 2010, GSK is to file a status report on each of these files and propose a timetable or amendments to an existing timetable for each. If not on consent, parties opposite are to respond by October 12, 2010 and request case conferences which will be held separately in any file where there is no consent to a timetable." placed on file on 29-SEP-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-SEP-2010 re: counsel's correspondence dated September 7, 2010 and September 3, 2010

Letter from GSK dated 07-SEP-2010 providing a draft protective order on consent received on 07-SEP-2010

****** REMOVED ****** Letter from Plaintiff in T-14-09 (Apotex) dated 07-SEP-2010 in response to GSK's letter dated 3-Sep-2010 received on 07-SEP-2010

Letter from defendants dated 07-SEP-2010 in response to GSK's letter dated 3-Sep-2010 received on 07-SEP-2010

Letter from GSK dated 03-SEP-2010 Requesting the Court an extension on time until September 30, 2010 to comply with the Direction of Madam Aronovitch dated July 23, 2010. received on 03-SEP-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 30-AUG-2010 directing that Further to Ms. Sanft's letter dated August 27, 2010, requesting until September 9, 2010 to report on discussions regarding consolidation: "Granted" placed on file on 30-AUG-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 30-AUG-2010 re: GSK's letter dated 27-Aug-2010

Letter from GSK dated 27-AUG-2010 requesting an extension until September 9, 2010 to comply with the July 23, 2010 direction received on 27-AUG-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 23-JUL-2010 directing that " By the end of August 2010, the parties are to meet to see if they can find common ground with respect to any consolidation of the three actions at any point in the proceedings. By September 3, 2010, Mr. Kierans is to advise the Court as to any consensus by the parties' and in the alternative provide a date by which he will be serving and filing a motion to consolidate." placed on file on 23-JUL-2010 Confirmed in writing to the party(ies)

Ottawa 22-JUL-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss consolidation for purpose of trial Result of Hearing: Direction to follow held by way of video conference Senior Usher: P. Gendron Duration per day: 22-JUL-2010 from 02:08 to 03:30 Courtroom : Videoconference Room - 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: 1.5h Appearances: Patrick Kierans, Jordana Sanft and Keith Aguilera 416-216-4000 representing GSK Inc. et als Carol Hitchman 416-865-8259 representing Pharmascience et als Comments: Heard with T-14-09 and T-643-10 Minutes of Hearing entered in Vol. 827 page(s) 434 - 435 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Keith Aguilera confirming service of submissions dated 12-Jul-2010 on behalf of GSK upon all parties by telecopier on 12-JUL-2010 filed on 12-JUL-2010

Communication to the Court from the Registry dated 19-JUL-2010 re: in preparation for the CMC on 22-Jul-2010

Letter from Plaintiffs dated 12-JUL-2010 in response to the direction of the Court dated 10-Jun-2010 received on 12-JUL-2010

Letter from GSK dated 12-JUL-2010 in response to the Court's direction dated 10-Jun-2010 received on 12-JUL-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 12-JUL-2010 directing that Accept the document submitted on July 12, 2010 for filing. placed on file on 12-JUL-2010

****** REMOVED ****** Letter from Apotex Plaintiff in court file T-14-09 dated 12-JUL-2010 This letter is regarding the direction issued 10-JUN-2010. received on 12-JUL-2010

Communication to the Court from the Registry dated 05-JUL-2010 re: GSK's letter dated 30-Jun-2010

Memorandum to file from Julie Dulac dated 05-JUL-2010 further to the receipt of counsel for GSK's letter dated 30-Jun-2010, I advised the parties that Madam Aronovitch is away until July 12, 2010 and that the correspondence will be placed before her upon her return and that they are to abide by the agreed timeline as if she had endorsed it. The Order or direction will be issued upon her return placed on file.

Letter from GSK dated 30-JUN-2010 requesting an extension of time, on consent, to provide the Court with submissions with regards to consolidation until July 12, 2010 received on 30-JUN-2010

Solicitor's certificate of service on behalf of Jordana Sanft confirming service of Doc. 10 upon all parties by telecopier on 23-JUN-2010 filed on 23-JUN-2010

Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 23-JUN-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 10-JUN-2010 directing that "A case management conference by video conference will take place on July 22, 2010 commencing at 2:00 p.m. for 1.5 hours. For that purpose, by July 5, 2010, parties are to serve and file a statement of the issues for the trial in their proceeding; advantages and economies that might be realized by consolidating the hearings and impediments or problems, if any, to overcome." placed on file on 10-JUN-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 09-JUN-2010 re: GSK's letter dated June 4, 2010 and Pharmascience's letter dated June 1,2010

Letter from defendants dated 01-JUN-2010 advising that it will be the position of Pharmascience that the Apotex action should not be consolidated with the Pharmascience actions received on 01-JUN-2010

Letter from GSK dated 04-JUN-2010 in response to the direction of the Court dated May 27, 2010 providing their availability for a CMC received on 04-JUN-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 27-MAY-2010 directing that In light of the correspondence dated May 25, 2010 from Ms. Hitchman, the motion to be heard on July 20, 2010 is hereby adjourned sine die. The reply & defence to counterclaim are to be filed in accordance with the Rules. The dates proposed for a case conference are not available to the Court. As there are limited dates available in June parties should consider the weeks of July 12 and 19, 2010. As counsel in T-643-10 ought to be included in the consolidation discussion, the plaintiff is requested, by June 4, 2010 to file the dates of availability of all counsel during the weeks of July 12 and 19, 2010. placed on file on 27-MAY-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 27-MAY-2010 re: availability of parties for a CMC to discuss consolidation and trial dates and the fact that the motion to strike will not be filed by the defendant therefore no need for hearing date on July 20th and paragraph 1(a) of the May 18th Order needs to be amended and request in T-643-10 that the file be case managed by Madam Aronovitch was sent up to the Judicial Administrator on May 26, 2010

E-mail received from counsel for the defendants advising of their availability for a CMC to discuss consolidation and trial dates placed on file on 27-MAY-2010

Letter from defendants dated 25-MAY-2010 advising that they will not be bringing a motion to strike at this time but reserves the right to raise this issue at a later date or at trial received on 25-MAY-2010

Solicitor's certificate of service on behalf of ESTHER JEON confirming service of DEFENCE AND COUNTERCLAIM (DOC. 8) upon PLAINTIFFS by personal service on 25-MAY-2010 filed on 25-MAY-2010

DEFENCE AND COUNTERCLAIM (ONE CD CONTAINING SCHEDULE 'A' ATTACHED AND SENT DIRECTLY TO OTTAWA) filed on 25-MAY-2010

Letter from counsel for GSK dated 21-MAY-2010 providing their availability to discuss consolidation and securing trial dates received on 21-MAY-2010

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 19-MAY-2010 directing that "By May 21, 2010, parties are to provide their availability to attend a joint case management conference by videoconference for a duration of 1.5. hours, to discuss consolidating the proceeding for the purposes of hearing, that is consecutively, by the same judge, and the possibility of securing trial dates. Parties are to provide their availability for the weeks of May 31, June 7 and 14, 2010." placed on file on 19-MAY-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-MAY-2010 re: in preparation for the CMC of 14-May-2010

Order dated 18-MAY-2010 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: 1. A timetable be set for this proceeding as follows: (a) The plaintiffs shall file and serve a Reply to the Defendants' Statement of Defence, if any, no later than fifteen (15) days after the disposition of the defendants' motion (the Motion) in respect of the Amended Statement of Claim. (b) The Motion shall be heard on July 20, 2010, in Ottawa, for a duration of three (3) hours commencing at 9:30 a.m. At the conclusion of the hearing, parties shall provide a report on progress against this timetable. (c) For the purposes of the Motion, the defendants shall serve their motion record on May 25, 2010, and file, in Ottawa, on May 26, 2010. The plaintiffs shall serve on June 16, 2010, and file, in Ottawa, on June 17, 2010. (d) The parties shall exchange affidavits of documents relevant to all matters in issue and copies of any documents referred to therein no later than June 30, 2010. Documents may be produced in an electronic format. (e) Examinations for discovery shall be completed no later than October 29, 2010. (f) Answers to undertakings made during the examinations for discovery shall be exchanged no later than December 23, 2010. (g) Any notices of motion with a list of questions attached arising from the examinations for discovery shall be served and filed no later than January 31, 2011. Filed on 18-MAY-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1089 page(s) 220 - 222 Interlocutory Decision

Ottawa 14-MAY-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the schedule Result of Hearing: Order re schedule and Direction re CMC (to be scheduled) to follow held in chambers by way of Conference Call Duration per day: 14-MAY-2010 from 10:00 to 10:30 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Jordana Sanft and Jane Caskey 416-216-3904 representing Plaintiffs Carol Hitchman 416-865-8259 representing Defendants Comments: The defendant's motion re: amended statement of claim is to be filed on May 26, 2010. The response by June 17, 2010 and the hearing of the motion is scheduled on July 20, 2010 in Ottawa for 3 hours Minutes of Hearing entered in Vol. 823 page(s) 389 - 392 Abstract of Hearing placed on file

Letter from the Plaintiffs dated 13-MAY-2010 attaching a proposed scheduling Order and suggesting that dates for the hearing of the Defendant's motion, yet to be filed, re: the Amended Statement of Claim, be discussed received on 13-MAY-2010

Communication to the Court from the Registry dated 13-MAY-2010 re: in preparation for the CMC on May 14, 2010

Solicitor's certificate of service on behalf of Jordana Sanft confirming service of Doc. 5 upon Defendant by personal service on 03-MAY-2010 filed on 03-MAY-2010

Amended Statement of Claim filed on 03-MAY-2010

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 28-APR-2010 directing that 1. The plaintiffs may serve and file an Amended Statement of Claim adding parties as plaintiffs to this action. 2. The defendants shall serve and file a Statement of Defence, if any, no later than three weeks after service of the plaintiffs' Amended Statement of Claim. The defendants may serve and file a motion seeking to strike all or part of the Amended Statement of Claim, no later than the date on which the defendants serve and file their Statement of Defence. 3. A further case management conference is to be held on May 14, 2010, at 10:00 a.m. for one hour to discuss the timetable of this action placed on file on 29-APR-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 26-APR-2010 re: forwarding the draft direction to the Court electronically

Letter from plaintiffs dated 26-APR-2010 attaching a draft direction further to the CMC held on April 23, 2010 received on 26-APR-2010

Ottawa 23-APR-2010 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss the proposed timetable Result of Hearing: Counsel for the Plaintiffs is to submit a draft direction by the end of the day on April 26, 2010 which says that the defence is to be serve and filed 3 weeks after service of the amended statement of claim, and talks about a motion to strike on behalf of the defendant and scheduled a further CMC on May 14, 2010 at 10:00 to discuss the timetable held in chambers by way of Conference Call Duration per day: 23-APR-2010 from 10:00 to 10:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 20min Appearances: Patrick Kierans 416-216-3904 representing Plaintiffs Carol Hitchman 416-865-8259 representing Defendants Minutes of Hearing entered in Vol. 822 page(s) 276 - 278 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 23-APR-2010 re: in preparation for the CMC today at 10:00

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 15-APR-2010 directing that a case management teleconference is scheduled on April 23, 2010 at 10:00 a.m. placed on file on 15-APR-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-APR-2010 re: parties' availability for a CMC

Letter from Defendants dated 09-APR-2010 providing her availability for a CMC received on 12-APR-2010

Letter from Plaintiffs dated 12-APR-2010 providing their availability for a CMC received on 12-APR-2010

Solicitor's certificate of service on behalf of Patrick Kierans confirming service of draft order attached to the March 15th letter upon the Defendants by telecopier on 15-MAR-2010 filed on 18-MAR-2010

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 08-APR-2010 directing that "By no later than April 12, 2010 parties are to provide their availability to attend a case conference in the two weeks following to discuss the proposed timetable." placed on file on 08-APR-2010 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 24-MAR-2010 re: the defendant's letter and proposed timetable dated March 22, 2010

Letter from PLAINTIFFS dated 17-MAR-2010 RE: PLAINTIFFS' LETTER DATED 15-MAR-2010 CORRECTING TYPOGRAPHICAL ERROR ON THE SOLICITOR'S CERTIFICATE OF SERVICE ATTACHED TO LETTER DATED 15-MAR-2010 received on 18-MAR-2010

Letter from Defendant to Case Management Team dated 22-MAR-2010 This letter is in response to the Order of Chief Justice dated 22-Feb-2010 as to Mr.Kierans' proposed schedule,we have propose the following schedule see document. received on 22-MAR-2010

Communication to the Court from the Registry dated 22-MAR-2010 re: Plaintiffs' letter dated March 15,2010

Letter from PLAINTIFFS dated 15-MAR-2010 RE: ORDER OF THE CHIEF JUSTICE DATED FEBRUARY 22, 2010 ADVISING A PROPOSED SCHEDULE HAS BEEN FORWARDED TO DEFENDANTS' COUNSEL AND THE PLAINTIFFS CURRENTLY AWAITING FOR COMMENT AND, IF IN AGREEMENT, CONSENT. (WITH ATTACHED PROPOSED TIMETABLE PURSUANT TO PARAGRAPHS 2 AND 3 OF ORDER) received on 15-MAR-2010

Communication to the Court from the Registry dated 01-MAR-2010 re: Order of the Court dated February 22, 2010

Order dated 22-FEB-2010 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 23-DEC-2009 Result: 1. This proceeding shall continue as a specially managed proceeding. 2. The plaintiff, within 20 days of the date of this order, shall serve and file a proposed timetable for the completion of the steps necessary to advance the proceeding in an expeditious manner. 3. The plaintiff shall consult with the defendant prior to the filing of the proposed timetable and indicate with its filing whether the timetable has been consented to by the defendant. 4. Pursuant to Rule 383, Prothonotary Roza Aronovitch is assigned as Case Management Judge in this matter. Filed on 22-FEB-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1080 page(s) 267 - 268 Interlocutory Decision

Letter from Plaintiff to Federal Court dated 23-DEC-2009 ...this letter be brought to the attention of Prothonotary Aronovitch. We are writing on bhalf of the Plaintiffs to seek an Order, pursuant to section 384 of the Federal Court Rules, to seek case management for Court File No. T-2101-09... received on 23-DEC-2009

Solicitor's certificate of service on behalf of Jordana Sanft confirming service of Doc. 1 upon Defendants--Pharmascience Inc., Laboratoire Riva Inc., Pro Doc Limitée by overnight courier on 18-DEC-2009 confirming service Doc. 1 upon Defendants--Dominion Pharmacal, Zymcan Pharmaceuticals,Pharmel Inc. by overnight courier on 18-DEC-2009 filed on 23-DEC-2009

Statement of Claim filed on 16-DEC-2009 Tariff other action - $150.00